Subject Accession	Species	Race	Race Specify	Ethnicity	Strain	Gender	Age Event	Age Event Specify	Subject Age	Age Unit	Subject Phenotype	ARM Accession	ARM Name	Study Accession	Study Brief Title	Biosample Accession	Biosample Description	Biosample Name	Biosample Type	Biosample Subtype	Study Time Collected	Study Time Collected Unit	Study Time T0 Event	Study Time T0 Event Specify	Biosample Treatment	Planned Visit Accession	Planned Visit Name	Experiment Accession	Expsample Accession	Expsample Description	Expsample Result Schema	Expsample Treatement	Reagent Accession	Reagent Name	Reagent Reporter Name	File Info ID	File Detail	File Name	Original File Name
SUB122732	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		46	Years	Healthy	ARM2107	AIRFV 2012-13	SDY301	Systems Biology Approach to Analysis of 2012-13 TIV Fluzone Influenza Vaccine Response in Healthy Individuals (see companion studies SDY74, SDY296)	BS720957			Other		0	Days	Time of initial vaccine administration			PV2143	1	EXP13728	ES789718		OTHER	SDY-300_C2_NONE	ESR12499, ESR12500, ESR12501, ESR12502, ESR12503, ESR12504, ESR12505, ESR12506, ESR12507, ESR12508, ESR12509	TRUSEQ RNA SAMPLE PREP KIT V2_Box A, TRUSEQ RNA SAMPLE PREP KIT V2_Box 1, TRUSEQ RNA SAMPLE PREP KIT V2_Box 2_8441530/8527616 combined, TRUSEQ RNA SAMPLE PREP KIT V2_PCR Box, Cluster generation_Reagent_GA2001014-PE3/GA2158702-PE3, Cluster generation_Flow cell_COUMKACXX/D16B4ACXX, Cluster generation_Manifold, TRUSEQ PE CLUSTER KIT V3_Box 2_RGT2020137/RGT2158708, SBS reagents_SBS box 1_RGT2120666/RGT2167122, SBS reagents_SBS box 2_RGT2176218/REA0266475, SBS reagents_TRUSEQ MULTIPLEX_RGT2090581/REA0207987		703279	RNA sequencing result	SDY301_EXP13728_RNA_seq.703279.tsv	SDY301_EXP13728_RNA_seq.tsv
SUB122732	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		46	Years	Healthy	ARM2107	AIRFV 2012-13	SDY301	Systems Biology Approach to Analysis of 2012-13 TIV Fluzone Influenza Vaccine Response in Healthy Individuals (see companion studies SDY74, SDY296)	BS720983			Other		0	Days	Time of initial vaccine administration			PV2143	1	EXP13728	ES789744		OTHER	SDY-300_C2_NONE	ESR12499, ESR12500, ESR12501, ESR12502, ESR12503, ESR12504, ESR12505, ESR12506, ESR12507, ESR12508, ESR12509	TRUSEQ RNA SAMPLE PREP KIT V2_Box A, TRUSEQ RNA SAMPLE PREP KIT V2_Box 1, TRUSEQ RNA SAMPLE PREP KIT V2_Box 2_8441530/8527616 combined, TRUSEQ RNA SAMPLE PREP KIT V2_PCR Box, Cluster generation_Reagent_GA2001014-PE3/GA2158702-PE3, Cluster generation_Flow cell_COUMKACXX/D16B4ACXX, Cluster generation_Manifold, TRUSEQ PE CLUSTER KIT V3_Box 2_RGT2020137/RGT2158708, SBS reagents_SBS box 1_RGT2120666/RGT2167122, SBS reagents_SBS box 2_RGT2176218/REA0266475, SBS reagents_TRUSEQ MULTIPLEX_RGT2090581/REA0207987		703279	RNA sequencing result	SDY301_EXP13728_RNA_seq.703279.tsv	SDY301_EXP13728_RNA_seq.tsv
SUB122732	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		46	Years	Healthy	ARM2107	AIRFV 2012-13	SDY301	Systems Biology Approach to Analysis of 2012-13 TIV Fluzone Influenza Vaccine Response in Healthy Individuals (see companion studies SDY74, SDY296)	BS721007			Other		0	Days	Time of initial vaccine administration			PV2143	1	EXP13728	ES789768		OTHER	SDY-300_C2_NONE	ESR12499, ESR12500, ESR12501, ESR12502, ESR12503, ESR12504, ESR12505, ESR12506, ESR12507, ESR12508, ESR12509	TRUSEQ RNA SAMPLE PREP KIT V2_Box A, TRUSEQ RNA SAMPLE PREP KIT V2_Box 1, TRUSEQ RNA SAMPLE PREP KIT V2_Box 2_8441530/8527616 combined, TRUSEQ RNA SAMPLE PREP KIT V2_PCR Box, Cluster generation_Reagent_GA2001014-PE3/GA2158702-PE3, Cluster generation_Flow cell_COUMKACXX/D16B4ACXX, Cluster generation_Manifold, TRUSEQ PE CLUSTER KIT V3_Box 2_RGT2020137/RGT2158708, SBS reagents_SBS box 1_RGT2120666/RGT2167122, SBS reagents_SBS box 2_RGT2176218/REA0266475, SBS reagents_TRUSEQ MULTIPLEX_RGT2090581/REA0207987		703279	RNA sequencing result	SDY301_EXP13728_RNA_seq.703279.tsv	SDY301_EXP13728_RNA_seq.tsv
SUB122732	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		46	Years	Healthy	ARM2107	AIRFV 2012-13	SDY301	Systems Biology Approach to Analysis of 2012-13 TIV Fluzone Influenza Vaccine Response in Healthy Individuals (see companion studies SDY74, SDY296)	BS721035			Other		0	Days	Time of initial vaccine administration			PV2143	1	EXP13728	ES789796		OTHER	SDY-300_C2_NONE	ESR12499, ESR12500, ESR12501, ESR12502, ESR12503, ESR12504, ESR12505, ESR12506, ESR12507, ESR12508, ESR12509	TRUSEQ RNA SAMPLE PREP KIT V2_Box A, TRUSEQ RNA SAMPLE PREP KIT V2_Box 1, TRUSEQ RNA SAMPLE PREP KIT V2_Box 2_8441530/8527616 combined, TRUSEQ RNA SAMPLE PREP KIT V2_PCR Box, Cluster generation_Reagent_GA2001014-PE3/GA2158702-PE3, Cluster generation_Flow cell_COUMKACXX/D16B4ACXX, Cluster generation_Manifold, TRUSEQ PE CLUSTER KIT V3_Box 2_RGT2020137/RGT2158708, SBS reagents_SBS box 1_RGT2120666/RGT2167122, SBS reagents_SBS box 2_RGT2176218/REA0266475, SBS reagents_TRUSEQ MULTIPLEX_RGT2090581/REA0207987		703279	RNA sequencing result	SDY301_EXP13728_RNA_seq.703279.tsv	SDY301_EXP13728_RNA_seq.tsv
SUB122733	Homo sapiens	Black or African American		Not Hispanic or Latino		Female	Age at enrollment		22	Years	Healthy	ARM2107	AIRFV 2012-13	SDY301	Systems Biology Approach to Analysis of 2012-13 TIV Fluzone Influenza Vaccine Response in Healthy Individuals (see companion studies SDY74, SDY296)	BS720985			Other		0	Days	Time of initial vaccine administration			PV2143	1	EXP13728	ES789746		OTHER	SDY-300_C2_NONE	ESR12499, ESR12500, ESR12501, ESR12502, ESR12503, ESR12504, ESR12505, ESR12506, ESR12507, ESR12508, ESR12509	TRUSEQ RNA SAMPLE PREP KIT V2_Box A, TRUSEQ RNA SAMPLE PREP KIT V2_Box 1, TRUSEQ RNA SAMPLE PREP KIT V2_Box 2_8441530/8527616 combined, TRUSEQ RNA SAMPLE PREP KIT V2_PCR Box, Cluster generation_Reagent_GA2001014-PE3/GA2158702-PE3, Cluster generation_Flow cell_COUMKACXX/D16B4ACXX, Cluster generation_Manifold, TRUSEQ PE CLUSTER KIT V3_Box 2_RGT2020137/RGT2158708, SBS reagents_SBS box 1_RGT2120666/RGT2167122, SBS reagents_SBS box 2_RGT2176218/REA0266475, SBS reagents_TRUSEQ MULTIPLEX_RGT2090581/REA0207987		703279	RNA sequencing result	SDY301_EXP13728_RNA_seq.703279.tsv	SDY301_EXP13728_RNA_seq.tsv
SUB122733	Homo sapiens	Black or African American		Not Hispanic or Latino		Female	Age at enrollment		22	Years	Healthy	ARM2107	AIRFV 2012-13	SDY301	Systems Biology Approach to Analysis of 2012-13 TIV Fluzone Influenza Vaccine Response in Healthy Individuals (see companion studies SDY74, SDY296)	BS721010			Other		0	Days	Time of initial vaccine administration			PV2143	1	EXP13728	ES789771		OTHER	SDY-300_C2_NONE	ESR12499, ESR12500, ESR12501, ESR12502, ESR12503, ESR12504, ESR12505, ESR12506, ESR12507, ESR12508, ESR12509	TRUSEQ RNA SAMPLE PREP KIT V2_Box A, TRUSEQ RNA SAMPLE PREP KIT V2_Box 1, TRUSEQ RNA SAMPLE PREP KIT V2_Box 2_8441530/8527616 combined, TRUSEQ RNA SAMPLE PREP KIT V2_PCR Box, Cluster generation_Reagent_GA2001014-PE3/GA2158702-PE3, Cluster generation_Flow cell_COUMKACXX/D16B4ACXX, Cluster generation_Manifold, TRUSEQ PE CLUSTER KIT V3_Box 2_RGT2020137/RGT2158708, SBS reagents_SBS box 1_RGT2120666/RGT2167122, SBS reagents_SBS box 2_RGT2176218/REA0266475, SBS reagents_TRUSEQ MULTIPLEX_RGT2090581/REA0207987		703279	RNA sequencing result	SDY301_EXP13728_RNA_seq.703279.tsv	SDY301_EXP13728_RNA_seq.tsv
SUB122733	Homo sapiens	Black or African American		Not Hispanic or Latino		Female	Age at enrollment		22	Years	Healthy	ARM2107	AIRFV 2012-13	SDY301	Systems Biology Approach to Analysis of 2012-13 TIV Fluzone Influenza Vaccine Response in Healthy Individuals (see companion studies SDY74, SDY296)	BS721038			Other		0	Days	Time of initial vaccine administration			PV2143	1	EXP13728	ES789799		OTHER	SDY-300_C2_NONE	ESR12499, ESR12500, ESR12501, ESR12502, ESR12503, ESR12504, ESR12505, ESR12506, ESR12507, ESR12508, ESR12509	TRUSEQ RNA SAMPLE PREP KIT V2_Box A, TRUSEQ RNA SAMPLE PREP KIT V2_Box 1, TRUSEQ RNA SAMPLE PREP KIT V2_Box 2_8441530/8527616 combined, TRUSEQ RNA SAMPLE PREP KIT V2_PCR Box, Cluster generation_Reagent_GA2001014-PE3/GA2158702-PE3, Cluster generation_Flow cell_COUMKACXX/D16B4ACXX, Cluster generation_Manifold, TRUSEQ PE CLUSTER KIT V3_Box 2_RGT2020137/RGT2158708, SBS reagents_SBS box 1_RGT2120666/RGT2167122, SBS reagents_SBS box 2_RGT2176218/REA0266475, SBS reagents_TRUSEQ MULTIPLEX_RGT2090581/REA0207987		703279	RNA sequencing result	SDY301_EXP13728_RNA_seq.703279.tsv	SDY301_EXP13728_RNA_seq.tsv
SUB122734	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		55	Years	Healthy	ARM2107	AIRFV 2012-13	SDY301	Systems Biology Approach to Analysis of 2012-13 TIV Fluzone Influenza Vaccine Response in Healthy Individuals (see companion studies SDY74, SDY296)	BS720959			Other		0	Days	Time of initial vaccine administration			PV2143	1	EXP13728	ES789720		OTHER	SDY-300_C2_NONE	ESR12499, ESR12500, ESR12501, ESR12502, ESR12503, ESR12504, ESR12505, ESR12506, ESR12507, ESR12508, ESR12509	TRUSEQ RNA SAMPLE PREP KIT V2_Box A, TRUSEQ RNA SAMPLE PREP KIT V2_Box 1, TRUSEQ RNA SAMPLE PREP KIT V2_Box 2_8441530/8527616 combined, TRUSEQ RNA SAMPLE PREP KIT V2_PCR Box, Cluster generation_Reagent_GA2001014-PE3/GA2158702-PE3, Cluster generation_Flow cell_COUMKACXX/D16B4ACXX, Cluster generation_Manifold, TRUSEQ PE CLUSTER KIT V3_Box 2_RGT2020137/RGT2158708, SBS reagents_SBS box 1_RGT2120666/RGT2167122, SBS reagents_SBS box 2_RGT2176218/REA0266475, SBS reagents_TRUSEQ MULTIPLEX_RGT2090581/REA0207987		703279	RNA sequencing result	SDY301_EXP13728_RNA_seq.703279.tsv	SDY301_EXP13728_RNA_seq.tsv
SUB122734	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		55	Years	Healthy	ARM2107	AIRFV 2012-13	SDY301	Systems Biology Approach to Analysis of 2012-13 TIV Fluzone Influenza Vaccine Response in Healthy Individuals (see companion studies SDY74, SDY296)	BS721011			Other		0	Days	Time of initial vaccine administration			PV2143	1	EXP13728	ES789772		OTHER	SDY-300_C2_NONE	ESR12499, ESR12500, ESR12501, ESR12502, ESR12503, ESR12504, ESR12505, ESR12506, ESR12507, ESR12508, ESR12509	TRUSEQ RNA SAMPLE PREP KIT V2_Box A, TRUSEQ RNA SAMPLE PREP KIT V2_Box 1, TRUSEQ RNA SAMPLE PREP KIT V2_Box 2_8441530/8527616 combined, TRUSEQ RNA SAMPLE PREP KIT V2_PCR Box, Cluster generation_Reagent_GA2001014-PE3/GA2158702-PE3, Cluster generation_Flow cell_COUMKACXX/D16B4ACXX, Cluster generation_Manifold, TRUSEQ PE CLUSTER KIT V3_Box 2_RGT2020137/RGT2158708, SBS reagents_SBS box 1_RGT2120666/RGT2167122, SBS reagents_SBS box 2_RGT2176218/REA0266475, SBS reagents_TRUSEQ MULTIPLEX_RGT2090581/REA0207987		703279	RNA sequencing result	SDY301_EXP13728_RNA_seq.703279.tsv	SDY301_EXP13728_RNA_seq.tsv
SUB122734	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		55	Years	Healthy	ARM2107	AIRFV 2012-13	SDY301	Systems Biology Approach to Analysis of 2012-13 TIV Fluzone Influenza Vaccine Response in Healthy Individuals (see companion studies SDY74, SDY296)	BS721039			Other		0	Days	Time of initial vaccine administration			PV2143	1	EXP13728	ES789800		OTHER	SDY-300_C2_NONE	ESR12499, ESR12500, ESR12501, ESR12502, ESR12503, ESR12504, ESR12505, ESR12506, ESR12507, ESR12508, ESR12509	TRUSEQ RNA SAMPLE PREP KIT V2_Box A, TRUSEQ RNA SAMPLE PREP KIT V2_Box 1, TRUSEQ RNA SAMPLE PREP KIT V2_Box 2_8441530/8527616 combined, TRUSEQ RNA SAMPLE PREP KIT V2_PCR Box, Cluster generation_Reagent_GA2001014-PE3/GA2158702-PE3, Cluster generation_Flow cell_COUMKACXX/D16B4ACXX, Cluster generation_Manifold, TRUSEQ PE CLUSTER KIT V3_Box 2_RGT2020137/RGT2158708, SBS reagents_SBS box 1_RGT2120666/RGT2167122, SBS reagents_SBS box 2_RGT2176218/REA0266475, SBS reagents_TRUSEQ MULTIPLEX_RGT2090581/REA0207987		703279	RNA sequencing result	SDY301_EXP13728_RNA_seq.703279.tsv	SDY301_EXP13728_RNA_seq.tsv
SUB122735	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		43	Years	Healthy	ARM2107	AIRFV 2012-13	SDY301	Systems Biology Approach to Analysis of 2012-13 TIV Fluzone Influenza Vaccine Response in Healthy Individuals (see companion studies SDY74, SDY296)	BS720968			Other		0	Days	Time of initial vaccine administration			PV2143	1	EXP13728	ES789729		OTHER	SDY-300_C2_NONE	ESR12499, ESR12500, ESR12501, ESR12502, ESR12503, ESR12504, ESR12505, ESR12506, ESR12507, ESR12508, ESR12509	TRUSEQ RNA SAMPLE PREP KIT V2_Box A, TRUSEQ RNA SAMPLE PREP KIT V2_Box 1, TRUSEQ RNA SAMPLE PREP KIT V2_Box 2_8441530/8527616 combined, TRUSEQ RNA SAMPLE PREP KIT V2_PCR Box, Cluster generation_Reagent_GA2001014-PE3/GA2158702-PE3, Cluster generation_Flow cell_COUMKACXX/D16B4ACXX, Cluster generation_Manifold, TRUSEQ PE CLUSTER KIT V3_Box 2_RGT2020137/RGT2158708, SBS reagents_SBS box 1_RGT2120666/RGT2167122, SBS reagents_SBS box 2_RGT2176218/REA0266475, SBS reagents_TRUSEQ MULTIPLEX_RGT2090581/REA0207987		703279	RNA sequencing result	SDY301_EXP13728_RNA_seq.703279.tsv	SDY301_EXP13728_RNA_seq.tsv
SUB122735	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		43	Years	Healthy	ARM2107	AIRFV 2012-13	SDY301	Systems Biology Approach to Analysis of 2012-13 TIV Fluzone Influenza Vaccine Response in Healthy Individuals (see companion studies SDY74, SDY296)	BS720993			Other		0	Days	Time of initial vaccine administration			PV2143	1	EXP13728	ES789754		OTHER	SDY-300_C2_NONE	ESR12499, ESR12500, ESR12501, ESR12502, ESR12503, ESR12504, ESR12505, ESR12506, ESR12507, ESR12508, ESR12509	TRUSEQ RNA SAMPLE PREP KIT V2_Box A, TRUSEQ RNA SAMPLE PREP KIT V2_Box 1, TRUSEQ RNA SAMPLE PREP KIT V2_Box 2_8441530/8527616 combined, TRUSEQ RNA SAMPLE PREP KIT V2_PCR Box, Cluster generation_Reagent_GA2001014-PE3/GA2158702-PE3, Cluster generation_Flow cell_COUMKACXX/D16B4ACXX, Cluster generation_Manifold, TRUSEQ PE CLUSTER KIT V3_Box 2_RGT2020137/RGT2158708, SBS reagents_SBS box 1_RGT2120666/RGT2167122, SBS reagents_SBS box 2_RGT2176218/REA0266475, SBS reagents_TRUSEQ MULTIPLEX_RGT2090581/REA0207987		703279	RNA sequencing result	SDY301_EXP13728_RNA_seq.703279.tsv	SDY301_EXP13728_RNA_seq.tsv
SUB122735	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		43	Years	Healthy	ARM2107	AIRFV 2012-13	SDY301	Systems Biology Approach to Analysis of 2012-13 TIV Fluzone Influenza Vaccine Response in Healthy Individuals (see companion studies SDY74, SDY296)	BS721022			Other		0	Days	Time of initial vaccine administration			PV2143	1	EXP13728	ES789783		OTHER	SDY-300_C2_NONE	ESR12499, ESR12500, ESR12501, ESR12502, ESR12503, ESR12504, ESR12505, ESR12506, ESR12507, ESR12508, ESR12509	TRUSEQ RNA SAMPLE PREP KIT V2_Box A, TRUSEQ RNA SAMPLE PREP KIT V2_Box 1, TRUSEQ RNA SAMPLE PREP KIT V2_Box 2_8441530/8527616 combined, TRUSEQ RNA SAMPLE PREP KIT V2_PCR Box, Cluster generation_Reagent_GA2001014-PE3/GA2158702-PE3, Cluster generation_Flow cell_COUMKACXX/D16B4ACXX, Cluster generation_Manifold, TRUSEQ PE CLUSTER KIT V3_Box 2_RGT2020137/RGT2158708, SBS reagents_SBS box 1_RGT2120666/RGT2167122, SBS reagents_SBS box 2_RGT2176218/REA0266475, SBS reagents_TRUSEQ MULTIPLEX_RGT2090581/REA0207987		703279	RNA sequencing result	SDY301_EXP13728_RNA_seq.703279.tsv	SDY301_EXP13728_RNA_seq.tsv
SUB122735	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		43	Years	Healthy	ARM2107	AIRFV 2012-13	SDY301	Systems Biology Approach to Analysis of 2012-13 TIV Fluzone Influenza Vaccine Response in Healthy Individuals (see companion studies SDY74, SDY296)	BS721050			Other		0	Days	Time of initial vaccine administration			PV2143	1	EXP13728	ES789811		OTHER	SDY-300_C2_NONE	ESR12499, ESR12500, ESR12501, ESR12502, ESR12503, ESR12504, ESR12505, ESR12506, ESR12507, ESR12508, ESR12509	TRUSEQ RNA SAMPLE PREP KIT V2_Box A, TRUSEQ RNA SAMPLE PREP KIT V2_Box 1, TRUSEQ RNA SAMPLE PREP KIT V2_Box 2_8441530/8527616 combined, TRUSEQ RNA SAMPLE PREP KIT V2_PCR Box, Cluster generation_Reagent_GA2001014-PE3/GA2158702-PE3, Cluster generation_Flow cell_COUMKACXX/D16B4ACXX, Cluster generation_Manifold, TRUSEQ PE CLUSTER KIT V3_Box 2_RGT2020137/RGT2158708, SBS reagents_SBS box 1_RGT2120666/RGT2167122, SBS reagents_SBS box 2_RGT2176218/REA0266475, SBS reagents_TRUSEQ MULTIPLEX_RGT2090581/REA0207987		703279	RNA sequencing result	SDY301_EXP13728_RNA_seq.703279.tsv	SDY301_EXP13728_RNA_seq.tsv
SUB122737	Homo sapiens	Black or African American		Not Hispanic or Latino		Female	Age at enrollment		51	Years	Healthy	ARM2107	AIRFV 2012-13	SDY301	Systems Biology Approach to Analysis of 2012-13 TIV Fluzone Influenza Vaccine Response in Healthy Individuals (see companion studies SDY74, SDY296)	BS721012			Other		0	Days	Time of initial vaccine administration			PV2143	1	EXP13728	ES789773		OTHER	SDY-300_C2_NONE	ESR12499, ESR12500, ESR12501, ESR12502, ESR12503, ESR12504, ESR12505, ESR12506, ESR12507, ESR12508, ESR12509	TRUSEQ RNA SAMPLE PREP KIT V2_Box A, TRUSEQ RNA SAMPLE PREP KIT V2_Box 1, TRUSEQ RNA SAMPLE PREP KIT V2_Box 2_8441530/8527616 combined, TRUSEQ RNA SAMPLE PREP KIT V2_PCR Box, Cluster generation_Reagent_GA2001014-PE3/GA2158702-PE3, Cluster generation_Flow cell_COUMKACXX/D16B4ACXX, Cluster generation_Manifold, TRUSEQ PE CLUSTER KIT V3_Box 2_RGT2020137/RGT2158708, SBS reagents_SBS box 1_RGT2120666/RGT2167122, SBS reagents_SBS box 2_RGT2176218/REA0266475, SBS reagents_TRUSEQ MULTIPLEX_RGT2090581/REA0207987		703279	RNA sequencing result	SDY301_EXP13728_RNA_seq.703279.tsv	SDY301_EXP13728_RNA_seq.tsv
SUB122737	Homo sapiens	Black or African American		Not Hispanic or Latino		Female	Age at enrollment		51	Years	Healthy	ARM2107	AIRFV 2012-13	SDY301	Systems Biology Approach to Analysis of 2012-13 TIV Fluzone Influenza Vaccine Response in Healthy Individuals (see companion studies SDY74, SDY296)	BS721040			Other		0	Days	Time of initial vaccine administration			PV2143	1	EXP13728	ES789801		OTHER	SDY-300_C2_NONE	ESR12499, ESR12500, ESR12501, ESR12502, ESR12503, ESR12504, ESR12505, ESR12506, ESR12507, ESR12508, ESR12509	TRUSEQ RNA SAMPLE PREP KIT V2_Box A, TRUSEQ RNA SAMPLE PREP KIT V2_Box 1, TRUSEQ RNA SAMPLE PREP KIT V2_Box 2_8441530/8527616 combined, TRUSEQ RNA SAMPLE PREP KIT V2_PCR Box, Cluster generation_Reagent_GA2001014-PE3/GA2158702-PE3, Cluster generation_Flow cell_COUMKACXX/D16B4ACXX, Cluster generation_Manifold, TRUSEQ PE CLUSTER KIT V3_Box 2_RGT2020137/RGT2158708, SBS reagents_SBS box 1_RGT2120666/RGT2167122, SBS reagents_SBS box 2_RGT2176218/REA0266475, SBS reagents_TRUSEQ MULTIPLEX_RGT2090581/REA0207987		703279	RNA sequencing result	SDY301_EXP13728_RNA_seq.703279.tsv	SDY301_EXP13728_RNA_seq.tsv
SUB122739	Homo sapiens	Black or African American		Not Hispanic or Latino		Male	Age at enrollment		36	Years	Healthy	ARM2107	AIRFV 2012-13	SDY301	Systems Biology Approach to Analysis of 2012-13 TIV Fluzone Influenza Vaccine Response in Healthy Individuals (see companion studies SDY74, SDY296)	BS720960			Other		0	Days	Time of initial vaccine administration			PV2143	1	EXP13728	ES789721		OTHER	SDY-300_C2_NONE	ESR12499, ESR12500, ESR12501, ESR12502, ESR12503, ESR12504, ESR12505, ESR12506, ESR12507, ESR12508, ESR12509	TRUSEQ RNA SAMPLE PREP KIT V2_Box A, TRUSEQ RNA SAMPLE PREP KIT V2_Box 1, TRUSEQ RNA SAMPLE PREP KIT V2_Box 2_8441530/8527616 combined, TRUSEQ RNA SAMPLE PREP KIT V2_PCR Box, Cluster generation_Reagent_GA2001014-PE3/GA2158702-PE3, Cluster generation_Flow cell_COUMKACXX/D16B4ACXX, Cluster generation_Manifold, TRUSEQ PE CLUSTER KIT V3_Box 2_RGT2020137/RGT2158708, SBS reagents_SBS box 1_RGT2120666/RGT2167122, SBS reagents_SBS box 2_RGT2176218/REA0266475, SBS reagents_TRUSEQ MULTIPLEX_RGT2090581/REA0207987		703279	RNA sequencing result	SDY301_EXP13728_RNA_seq.703279.tsv	SDY301_EXP13728_RNA_seq.tsv
SUB122739	Homo sapiens	Black or African American		Not Hispanic or Latino		Male	Age at enrollment		36	Years	Healthy	ARM2107	AIRFV 2012-13	SDY301	Systems Biology Approach to Analysis of 2012-13 TIV Fluzone Influenza Vaccine Response in Healthy Individuals (see companion studies SDY74, SDY296)	BS721013			Other		0	Days	Time of initial vaccine administration			PV2143	1	EXP13728	ES789774		OTHER	SDY-300_C2_NONE	ESR12499, ESR12500, ESR12501, ESR12502, ESR12503, ESR12504, ESR12505, ESR12506, ESR12507, ESR12508, ESR12509	TRUSEQ RNA SAMPLE PREP KIT V2_Box A, TRUSEQ RNA SAMPLE PREP KIT V2_Box 1, TRUSEQ RNA SAMPLE PREP KIT V2_Box 2_8441530/8527616 combined, TRUSEQ RNA SAMPLE PREP KIT V2_PCR Box, Cluster generation_Reagent_GA2001014-PE3/GA2158702-PE3, Cluster generation_Flow cell_COUMKACXX/D16B4ACXX, Cluster generation_Manifold, TRUSEQ PE CLUSTER KIT V3_Box 2_RGT2020137/RGT2158708, SBS reagents_SBS box 1_RGT2120666/RGT2167122, SBS reagents_SBS box 2_RGT2176218/REA0266475, SBS reagents_TRUSEQ MULTIPLEX_RGT2090581/REA0207987		703279	RNA sequencing result	SDY301_EXP13728_RNA_seq.703279.tsv	SDY301_EXP13728_RNA_seq.tsv
SUB122739	Homo sapiens	Black or African American		Not Hispanic or Latino		Male	Age at enrollment		36	Years	Healthy	ARM2107	AIRFV 2012-13	SDY301	Systems Biology Approach to Analysis of 2012-13 TIV Fluzone Influenza Vaccine Response in Healthy Individuals (see companion studies SDY74, SDY296)	BS721041			Other		0	Days	Time of initial vaccine administration			PV2143	1	EXP13728	ES789802		OTHER	SDY-300_C2_NONE	ESR12499, ESR12500, ESR12501, ESR12502, ESR12503, ESR12504, ESR12505, ESR12506, ESR12507, ESR12508, ESR12509	TRUSEQ RNA SAMPLE PREP KIT V2_Box A, TRUSEQ RNA SAMPLE PREP KIT V2_Box 1, TRUSEQ RNA SAMPLE PREP KIT V2_Box 2_8441530/8527616 combined, TRUSEQ RNA SAMPLE PREP KIT V2_PCR Box, Cluster generation_Reagent_GA2001014-PE3/GA2158702-PE3, Cluster generation_Flow cell_COUMKACXX/D16B4ACXX, Cluster generation_Manifold, TRUSEQ PE CLUSTER KIT V3_Box 2_RGT2020137/RGT2158708, SBS reagents_SBS box 1_RGT2120666/RGT2167122, SBS reagents_SBS box 2_RGT2176218/REA0266475, SBS reagents_TRUSEQ MULTIPLEX_RGT2090581/REA0207987		703279	RNA sequencing result	SDY301_EXP13728_RNA_seq.703279.tsv	SDY301_EXP13728_RNA_seq.tsv
SUB122740	Homo sapiens	Black or African American		Not Hispanic or Latino		Female	Age at enrollment		44	Years	Healthy	ARM2107	AIRFV 2012-13	SDY301	Systems Biology Approach to Analysis of 2012-13 TIV Fluzone Influenza Vaccine Response in Healthy Individuals (see companion studies SDY74, SDY296)	BS720961			Other		0	Days	Time of initial vaccine administration			PV2143	1	EXP13728	ES789722		OTHER	SDY-300_C2_NONE	ESR12499, ESR12500, ESR12501, ESR12502, ESR12503, ESR12504, ESR12505, ESR12506, ESR12507, ESR12508, ESR12509	TRUSEQ RNA SAMPLE PREP KIT V2_Box A, TRUSEQ RNA SAMPLE PREP KIT V2_Box 1, TRUSEQ RNA SAMPLE PREP KIT V2_Box 2_8441530/8527616 combined, TRUSEQ RNA SAMPLE PREP KIT V2_PCR Box, Cluster generation_Reagent_GA2001014-PE3/GA2158702-PE3, Cluster generation_Flow cell_COUMKACXX/D16B4ACXX, Cluster generation_Manifold, TRUSEQ PE CLUSTER KIT V3_Box 2_RGT2020137/RGT2158708, SBS reagents_SBS box 1_RGT2120666/RGT2167122, SBS reagents_SBS box 2_RGT2176218/REA0266475, SBS reagents_TRUSEQ MULTIPLEX_RGT2090581/REA0207987		703279	RNA sequencing result	SDY301_EXP13728_RNA_seq.703279.tsv	SDY301_EXP13728_RNA_seq.tsv
SUB122740	Homo sapiens	Black or African American		Not Hispanic or Latino		Female	Age at enrollment		44	Years	Healthy	ARM2107	AIRFV 2012-13	SDY301	Systems Biology Approach to Analysis of 2012-13 TIV Fluzone Influenza Vaccine Response in Healthy Individuals (see companion studies SDY74, SDY296)	BS720986			Other		0	Days	Time of initial vaccine administration			PV2143	1	EXP13728	ES789747		OTHER	SDY-300_C2_NONE	ESR12499, ESR12500, ESR12501, ESR12502, ESR12503, ESR12504, ESR12505, ESR12506, ESR12507, ESR12508, ESR12509	TRUSEQ RNA SAMPLE PREP KIT V2_Box A, TRUSEQ RNA SAMPLE PREP KIT V2_Box 1, TRUSEQ RNA SAMPLE PREP KIT V2_Box 2_8441530/8527616 combined, TRUSEQ RNA SAMPLE PREP KIT V2_PCR Box, Cluster generation_Reagent_GA2001014-PE3/GA2158702-PE3, Cluster generation_Flow cell_COUMKACXX/D16B4ACXX, Cluster generation_Manifold, TRUSEQ PE CLUSTER KIT V3_Box 2_RGT2020137/RGT2158708, SBS reagents_SBS box 1_RGT2120666/RGT2167122, SBS reagents_SBS box 2_RGT2176218/REA0266475, SBS reagents_TRUSEQ MULTIPLEX_RGT2090581/REA0207987		703279	RNA sequencing result	SDY301_EXP13728_RNA_seq.703279.tsv	SDY301_EXP13728_RNA_seq.tsv
SUB122740	Homo sapiens	Black or African American		Not Hispanic or Latino		Female	Age at enrollment		44	Years	Healthy	ARM2107	AIRFV 2012-13	SDY301	Systems Biology Approach to Analysis of 2012-13 TIV Fluzone Influenza Vaccine Response in Healthy Individuals (see companion studies SDY74, SDY296)	BS721014			Other		0	Days	Time of initial vaccine administration			PV2143	1	EXP13728	ES789775		OTHER	SDY-300_C2_NONE	ESR12499, ESR12500, ESR12501, ESR12502, ESR12503, ESR12504, ESR12505, ESR12506, ESR12507, ESR12508, ESR12509	TRUSEQ RNA SAMPLE PREP KIT V2_Box A, TRUSEQ RNA SAMPLE PREP KIT V2_Box 1, TRUSEQ RNA SAMPLE PREP KIT V2_Box 2_8441530/8527616 combined, TRUSEQ RNA SAMPLE PREP KIT V2_PCR Box, Cluster generation_Reagent_GA2001014-PE3/GA2158702-PE3, Cluster generation_Flow cell_COUMKACXX/D16B4ACXX, Cluster generation_Manifold, TRUSEQ PE CLUSTER KIT V3_Box 2_RGT2020137/RGT2158708, SBS reagents_SBS box 1_RGT2120666/RGT2167122, SBS reagents_SBS box 2_RGT2176218/REA0266475, SBS reagents_TRUSEQ MULTIPLEX_RGT2090581/REA0207987		703279	RNA sequencing result	SDY301_EXP13728_RNA_seq.703279.tsv	SDY301_EXP13728_RNA_seq.tsv
SUB122740	Homo sapiens	Black or African American		Not Hispanic or Latino		Female	Age at enrollment		44	Years	Healthy	ARM2107	AIRFV 2012-13	SDY301	Systems Biology Approach to Analysis of 2012-13 TIV Fluzone Influenza Vaccine Response in Healthy Individuals (see companion studies SDY74, SDY296)	BS721042			Other		0	Days	Time of initial vaccine administration			PV2143	1	EXP13728	ES789803		OTHER	SDY-300_C2_NONE	ESR12499, ESR12500, ESR12501, ESR12502, ESR12503, ESR12504, ESR12505, ESR12506, ESR12507, ESR12508, ESR12509	TRUSEQ RNA SAMPLE PREP KIT V2_Box A, TRUSEQ RNA SAMPLE PREP KIT V2_Box 1, TRUSEQ RNA SAMPLE PREP KIT V2_Box 2_8441530/8527616 combined, TRUSEQ RNA SAMPLE PREP KIT V2_PCR Box, Cluster generation_Reagent_GA2001014-PE3/GA2158702-PE3, Cluster generation_Flow cell_COUMKACXX/D16B4ACXX, Cluster generation_Manifold, TRUSEQ PE CLUSTER KIT V3_Box 2_RGT2020137/RGT2158708, SBS reagents_SBS box 1_RGT2120666/RGT2167122, SBS reagents_SBS box 2_RGT2176218/REA0266475, SBS reagents_TRUSEQ MULTIPLEX_RGT2090581/REA0207987		703279	RNA sequencing result	SDY301_EXP13728_RNA_seq.703279.tsv	SDY301_EXP13728_RNA_seq.tsv
SUB122742	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		58	Years	Healthy	ARM2107	AIRFV 2012-13	SDY301	Systems Biology Approach to Analysis of 2012-13 TIV Fluzone Influenza Vaccine Response in Healthy Individuals (see companion studies SDY74, SDY296)	BS720958			Other		0	Days	Time of initial vaccine administration			PV2143	1	EXP13728	ES789719		OTHER	SDY-300_C2_NONE	ESR12499, ESR12500, ESR12501, ESR12502, ESR12503, ESR12504, ESR12505, ESR12506, ESR12507, ESR12508, ESR12509	TRUSEQ RNA SAMPLE PREP KIT V2_Box A, TRUSEQ RNA SAMPLE PREP KIT V2_Box 1, TRUSEQ RNA SAMPLE PREP KIT V2_Box 2_8441530/8527616 combined, TRUSEQ RNA SAMPLE PREP KIT V2_PCR Box, Cluster generation_Reagent_GA2001014-PE3/GA2158702-PE3, Cluster generation_Flow cell_COUMKACXX/D16B4ACXX, Cluster generation_Manifold, TRUSEQ PE CLUSTER KIT V3_Box 2_RGT2020137/RGT2158708, SBS reagents_SBS box 1_RGT2120666/RGT2167122, SBS reagents_SBS box 2_RGT2176218/REA0266475, SBS reagents_TRUSEQ MULTIPLEX_RGT2090581/REA0207987		703279	RNA sequencing result	SDY301_EXP13728_RNA_seq.703279.tsv	SDY301_EXP13728_RNA_seq.tsv
SUB122742	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		58	Years	Healthy	ARM2107	AIRFV 2012-13	SDY301	Systems Biology Approach to Analysis of 2012-13 TIV Fluzone Influenza Vaccine Response in Healthy Individuals (see companion studies SDY74, SDY296)	BS721008			Other		0	Days	Time of initial vaccine administration			PV2143	1	EXP13728	ES789769		OTHER	SDY-300_C2_NONE	ESR12499, ESR12500, ESR12501, ESR12502, ESR12503, ESR12504, ESR12505, ESR12506, ESR12507, ESR12508, ESR12509	TRUSEQ RNA SAMPLE PREP KIT V2_Box A, TRUSEQ RNA SAMPLE PREP KIT V2_Box 1, TRUSEQ RNA SAMPLE PREP KIT V2_Box 2_8441530/8527616 combined, TRUSEQ RNA SAMPLE PREP KIT V2_PCR Box, Cluster generation_Reagent_GA2001014-PE3/GA2158702-PE3, Cluster generation_Flow cell_COUMKACXX/D16B4ACXX, Cluster generation_Manifold, TRUSEQ PE CLUSTER KIT V3_Box 2_RGT2020137/RGT2158708, SBS reagents_SBS box 1_RGT2120666/RGT2167122, SBS reagents_SBS box 2_RGT2176218/REA0266475, SBS reagents_TRUSEQ MULTIPLEX_RGT2090581/REA0207987		703279	RNA sequencing result	SDY301_EXP13728_RNA_seq.703279.tsv	SDY301_EXP13728_RNA_seq.tsv
SUB122742	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		58	Years	Healthy	ARM2107	AIRFV 2012-13	SDY301	Systems Biology Approach to Analysis of 2012-13 TIV Fluzone Influenza Vaccine Response in Healthy Individuals (see companion studies SDY74, SDY296)	BS721036			Other		0	Days	Time of initial vaccine administration			PV2143	1	EXP13728	ES789797		OTHER	SDY-300_C2_NONE	ESR12499, ESR12500, ESR12501, ESR12502, ESR12503, ESR12504, ESR12505, ESR12506, ESR12507, ESR12508, ESR12509	TRUSEQ RNA SAMPLE PREP KIT V2_Box A, TRUSEQ RNA SAMPLE PREP KIT V2_Box 1, TRUSEQ RNA SAMPLE PREP KIT V2_Box 2_8441530/8527616 combined, TRUSEQ RNA SAMPLE PREP KIT V2_PCR Box, Cluster generation_Reagent_GA2001014-PE3/GA2158702-PE3, Cluster generation_Flow cell_COUMKACXX/D16B4ACXX, Cluster generation_Manifold, TRUSEQ PE CLUSTER KIT V3_Box 2_RGT2020137/RGT2158708, SBS reagents_SBS box 1_RGT2120666/RGT2167122, SBS reagents_SBS box 2_RGT2176218/REA0266475, SBS reagents_TRUSEQ MULTIPLEX_RGT2090581/REA0207987		703279	RNA sequencing result	SDY301_EXP13728_RNA_seq.703279.tsv	SDY301_EXP13728_RNA_seq.tsv
SUB122743	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		56	Years	Healthy	ARM2107	AIRFV 2012-13	SDY301	Systems Biology Approach to Analysis of 2012-13 TIV Fluzone Influenza Vaccine Response in Healthy Individuals (see companion studies SDY74, SDY296)	BS720984			Other		0	Days	Time of initial vaccine administration			PV2143	1	EXP13728	ES789745		OTHER	SDY-300_C2_NONE	ESR12499, ESR12500, ESR12501, ESR12502, ESR12503, ESR12504, ESR12505, ESR12506, ESR12507, ESR12508, ESR12509	TRUSEQ RNA SAMPLE PREP KIT V2_Box A, TRUSEQ RNA SAMPLE PREP KIT V2_Box 1, TRUSEQ RNA SAMPLE PREP KIT V2_Box 2_8441530/8527616 combined, TRUSEQ RNA SAMPLE PREP KIT V2_PCR Box, Cluster generation_Reagent_GA2001014-PE3/GA2158702-PE3, Cluster generation_Flow cell_COUMKACXX/D16B4ACXX, Cluster generation_Manifold, TRUSEQ PE CLUSTER KIT V3_Box 2_RGT2020137/RGT2158708, SBS reagents_SBS box 1_RGT2120666/RGT2167122, SBS reagents_SBS box 2_RGT2176218/REA0266475, SBS reagents_TRUSEQ MULTIPLEX_RGT2090581/REA0207987		703279	RNA sequencing result	SDY301_EXP13728_RNA_seq.703279.tsv	SDY301_EXP13728_RNA_seq.tsv
SUB122743	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		56	Years	Healthy	ARM2107	AIRFV 2012-13	SDY301	Systems Biology Approach to Analysis of 2012-13 TIV Fluzone Influenza Vaccine Response in Healthy Individuals (see companion studies SDY74, SDY296)	BS721009			Other		0	Days	Time of initial vaccine administration			PV2143	1	EXP13728	ES789770		OTHER	SDY-300_C2_NONE	ESR12499, ESR12500, ESR12501, ESR12502, ESR12503, ESR12504, ESR12505, ESR12506, ESR12507, ESR12508, ESR12509	TRUSEQ RNA SAMPLE PREP KIT V2_Box A, TRUSEQ RNA SAMPLE PREP KIT V2_Box 1, TRUSEQ RNA SAMPLE PREP KIT V2_Box 2_8441530/8527616 combined, TRUSEQ RNA SAMPLE PREP KIT V2_PCR Box, Cluster generation_Reagent_GA2001014-PE3/GA2158702-PE3, Cluster generation_Flow cell_COUMKACXX/D16B4ACXX, Cluster generation_Manifold, TRUSEQ PE CLUSTER KIT V3_Box 2_RGT2020137/RGT2158708, SBS reagents_SBS box 1_RGT2120666/RGT2167122, SBS reagents_SBS box 2_RGT2176218/REA0266475, SBS reagents_TRUSEQ MULTIPLEX_RGT2090581/REA0207987		703279	RNA sequencing result	SDY301_EXP13728_RNA_seq.703279.tsv	SDY301_EXP13728_RNA_seq.tsv
SUB122743	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		56	Years	Healthy	ARM2107	AIRFV 2012-13	SDY301	Systems Biology Approach to Analysis of 2012-13 TIV Fluzone Influenza Vaccine Response in Healthy Individuals (see companion studies SDY74, SDY296)	BS721037			Other		0	Days	Time of initial vaccine administration			PV2143	1	EXP13728	ES789798		OTHER	SDY-300_C2_NONE	ESR12499, ESR12500, ESR12501, ESR12502, ESR12503, ESR12504, ESR12505, ESR12506, ESR12507, ESR12508, ESR12509	TRUSEQ RNA SAMPLE PREP KIT V2_Box A, TRUSEQ RNA SAMPLE PREP KIT V2_Box 1, TRUSEQ RNA SAMPLE PREP KIT V2_Box 2_8441530/8527616 combined, TRUSEQ RNA SAMPLE PREP KIT V2_PCR Box, Cluster generation_Reagent_GA2001014-PE3/GA2158702-PE3, Cluster generation_Flow cell_COUMKACXX/D16B4ACXX, Cluster generation_Manifold, TRUSEQ PE CLUSTER KIT V3_Box 2_RGT2020137/RGT2158708, SBS reagents_SBS box 1_RGT2120666/RGT2167122, SBS reagents_SBS box 2_RGT2176218/REA0266475, SBS reagents_TRUSEQ MULTIPLEX_RGT2090581/REA0207987		703279	RNA sequencing result	SDY301_EXP13728_RNA_seq.703279.tsv	SDY301_EXP13728_RNA_seq.tsv
SUB122744	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		22	Years	Healthy	ARM2107	AIRFV 2012-13	SDY301	Systems Biology Approach to Analysis of 2012-13 TIV Fluzone Influenza Vaccine Response in Healthy Individuals (see companion studies SDY74, SDY296)	BS720963			Other		0	Days	Time of initial vaccine administration			PV2143	1	EXP13728	ES789724		OTHER	SDY-300_C2_NONE	ESR12499, ESR12500, ESR12501, ESR12502, ESR12503, ESR12504, ESR12505, ESR12506, ESR12507, ESR12508, ESR12509	TRUSEQ RNA SAMPLE PREP KIT V2_Box A, TRUSEQ RNA SAMPLE PREP KIT V2_Box 1, TRUSEQ RNA SAMPLE PREP KIT V2_Box 2_8441530/8527616 combined, TRUSEQ RNA SAMPLE PREP KIT V2_PCR Box, Cluster generation_Reagent_GA2001014-PE3/GA2158702-PE3, Cluster generation_Flow cell_COUMKACXX/D16B4ACXX, Cluster generation_Manifold, TRUSEQ PE CLUSTER KIT V3_Box 2_RGT2020137/RGT2158708, SBS reagents_SBS box 1_RGT2120666/RGT2167122, SBS reagents_SBS box 2_RGT2176218/REA0266475, SBS reagents_TRUSEQ MULTIPLEX_RGT2090581/REA0207987		703279	RNA sequencing result	SDY301_EXP13728_RNA_seq.703279.tsv	SDY301_EXP13728_RNA_seq.tsv
SUB122744	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		22	Years	Healthy	ARM2107	AIRFV 2012-13	SDY301	Systems Biology Approach to Analysis of 2012-13 TIV Fluzone Influenza Vaccine Response in Healthy Individuals (see companion studies SDY74, SDY296)	BS720988			Other		0	Days	Time of initial vaccine administration			PV2143	1	EXP13728	ES789749		OTHER	SDY-300_C2_NONE	ESR12499, ESR12500, ESR12501, ESR12502, ESR12503, ESR12504, ESR12505, ESR12506, ESR12507, ESR12508, ESR12509	TRUSEQ RNA SAMPLE PREP KIT V2_Box A, TRUSEQ RNA SAMPLE PREP KIT V2_Box 1, TRUSEQ RNA SAMPLE PREP KIT V2_Box 2_8441530/8527616 combined, TRUSEQ RNA SAMPLE PREP KIT V2_PCR Box, Cluster generation_Reagent_GA2001014-PE3/GA2158702-PE3, Cluster generation_Flow cell_COUMKACXX/D16B4ACXX, Cluster generation_Manifold, TRUSEQ PE CLUSTER KIT V3_Box 2_RGT2020137/RGT2158708, SBS reagents_SBS box 1_RGT2120666/RGT2167122, SBS reagents_SBS box 2_RGT2176218/REA0266475, SBS reagents_TRUSEQ MULTIPLEX_RGT2090581/REA0207987		703279	RNA sequencing result	SDY301_EXP13728_RNA_seq.703279.tsv	SDY301_EXP13728_RNA_seq.tsv
SUB122744	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		22	Years	Healthy	ARM2107	AIRFV 2012-13	SDY301	Systems Biology Approach to Analysis of 2012-13 TIV Fluzone Influenza Vaccine Response in Healthy Individuals (see companion studies SDY74, SDY296)	BS721016			Other		0	Days	Time of initial vaccine administration			PV2143	1	EXP13728	ES789777		OTHER	SDY-300_C2_NONE	ESR12499, ESR12500, ESR12501, ESR12502, ESR12503, ESR12504, ESR12505, ESR12506, ESR12507, ESR12508, ESR12509	TRUSEQ RNA SAMPLE PREP KIT V2_Box A, TRUSEQ RNA SAMPLE PREP KIT V2_Box 1, TRUSEQ RNA SAMPLE PREP KIT V2_Box 2_8441530/8527616 combined, TRUSEQ RNA SAMPLE PREP KIT V2_PCR Box, Cluster generation_Reagent_GA2001014-PE3/GA2158702-PE3, Cluster generation_Flow cell_COUMKACXX/D16B4ACXX, Cluster generation_Manifold, TRUSEQ PE CLUSTER KIT V3_Box 2_RGT2020137/RGT2158708, SBS reagents_SBS box 1_RGT2120666/RGT2167122, SBS reagents_SBS box 2_RGT2176218/REA0266475, SBS reagents_TRUSEQ MULTIPLEX_RGT2090581/REA0207987		703279	RNA sequencing result	SDY301_EXP13728_RNA_seq.703279.tsv	SDY301_EXP13728_RNA_seq.tsv
SUB122744	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		22	Years	Healthy	ARM2107	AIRFV 2012-13	SDY301	Systems Biology Approach to Analysis of 2012-13 TIV Fluzone Influenza Vaccine Response in Healthy Individuals (see companion studies SDY74, SDY296)	BS721044			Other		0	Days	Time of initial vaccine administration			PV2143	1	EXP13728	ES789805		OTHER	SDY-300_C2_NONE	ESR12499, ESR12500, ESR12501, ESR12502, ESR12503, ESR12504, ESR12505, ESR12506, ESR12507, ESR12508, ESR12509	TRUSEQ RNA SAMPLE PREP KIT V2_Box A, TRUSEQ RNA SAMPLE PREP KIT V2_Box 1, TRUSEQ RNA SAMPLE PREP KIT V2_Box 2_8441530/8527616 combined, TRUSEQ RNA SAMPLE PREP KIT V2_PCR Box, Cluster generation_Reagent_GA2001014-PE3/GA2158702-PE3, Cluster generation_Flow cell_COUMKACXX/D16B4ACXX, Cluster generation_Manifold, TRUSEQ PE CLUSTER KIT V3_Box 2_RGT2020137/RGT2158708, SBS reagents_SBS box 1_RGT2120666/RGT2167122, SBS reagents_SBS box 2_RGT2176218/REA0266475, SBS reagents_TRUSEQ MULTIPLEX_RGT2090581/REA0207987		703279	RNA sequencing result	SDY301_EXP13728_RNA_seq.703279.tsv	SDY301_EXP13728_RNA_seq.tsv
SUB122747	Homo sapiens	Black or African American		Not Hispanic or Latino		Male	Age at enrollment		40	Years	Healthy	ARM2107	AIRFV 2012-13	SDY301	Systems Biology Approach to Analysis of 2012-13 TIV Fluzone Influenza Vaccine Response in Healthy Individuals (see companion studies SDY74, SDY296)	BS720964			Other		0	Days	Time of initial vaccine administration			PV2143	1	EXP13728	ES789725		OTHER	SDY-300_C2_NONE	ESR12499, ESR12500, ESR12501, ESR12502, ESR12503, ESR12504, ESR12505, ESR12506, ESR12507, ESR12508, ESR12509	TRUSEQ RNA SAMPLE PREP KIT V2_Box A, TRUSEQ RNA SAMPLE PREP KIT V2_Box 1, TRUSEQ RNA SAMPLE PREP KIT V2_Box 2_8441530/8527616 combined, TRUSEQ RNA SAMPLE PREP KIT V2_PCR Box, Cluster generation_Reagent_GA2001014-PE3/GA2158702-PE3, Cluster generation_Flow cell_COUMKACXX/D16B4ACXX, Cluster generation_Manifold, TRUSEQ PE CLUSTER KIT V3_Box 2_RGT2020137/RGT2158708, SBS reagents_SBS box 1_RGT2120666/RGT2167122, SBS reagents_SBS box 2_RGT2176218/REA0266475, SBS reagents_TRUSEQ MULTIPLEX_RGT2090581/REA0207987		703279	RNA sequencing result	SDY301_EXP13728_RNA_seq.703279.tsv	SDY301_EXP13728_RNA_seq.tsv
SUB122747	Homo sapiens	Black or African American		Not Hispanic or Latino		Male	Age at enrollment		40	Years	Healthy	ARM2107	AIRFV 2012-13	SDY301	Systems Biology Approach to Analysis of 2012-13 TIV Fluzone Influenza Vaccine Response in Healthy Individuals (see companion studies SDY74, SDY296)	BS720989			Other		0	Days	Time of initial vaccine administration			PV2143	1	EXP13728	ES789750		OTHER	SDY-300_C2_NONE	ESR12499, ESR12500, ESR12501, ESR12502, ESR12503, ESR12504, ESR12505, ESR12506, ESR12507, ESR12508, ESR12509	TRUSEQ RNA SAMPLE PREP KIT V2_Box A, TRUSEQ RNA SAMPLE PREP KIT V2_Box 1, TRUSEQ RNA SAMPLE PREP KIT V2_Box 2_8441530/8527616 combined, TRUSEQ RNA SAMPLE PREP KIT V2_PCR Box, Cluster generation_Reagent_GA2001014-PE3/GA2158702-PE3, Cluster generation_Flow cell_COUMKACXX/D16B4ACXX, Cluster generation_Manifold, TRUSEQ PE CLUSTER KIT V3_Box 2_RGT2020137/RGT2158708, SBS reagents_SBS box 1_RGT2120666/RGT2167122, SBS reagents_SBS box 2_RGT2176218/REA0266475, SBS reagents_TRUSEQ MULTIPLEX_RGT2090581/REA0207987		703279	RNA sequencing result	SDY301_EXP13728_RNA_seq.703279.tsv	SDY301_EXP13728_RNA_seq.tsv
SUB122747	Homo sapiens	Black or African American		Not Hispanic or Latino		Male	Age at enrollment		40	Years	Healthy	ARM2107	AIRFV 2012-13	SDY301	Systems Biology Approach to Analysis of 2012-13 TIV Fluzone Influenza Vaccine Response in Healthy Individuals (see companion studies SDY74, SDY296)	BS721017			Other		0	Days	Time of initial vaccine administration			PV2143	1	EXP13728	ES789778		OTHER	SDY-300_C2_NONE	ESR12499, ESR12500, ESR12501, ESR12502, ESR12503, ESR12504, ESR12505, ESR12506, ESR12507, ESR12508, ESR12509	TRUSEQ RNA SAMPLE PREP KIT V2_Box A, TRUSEQ RNA SAMPLE PREP KIT V2_Box 1, TRUSEQ RNA SAMPLE PREP KIT V2_Box 2_8441530/8527616 combined, TRUSEQ RNA SAMPLE PREP KIT V2_PCR Box, Cluster generation_Reagent_GA2001014-PE3/GA2158702-PE3, Cluster generation_Flow cell_COUMKACXX/D16B4ACXX, Cluster generation_Manifold, TRUSEQ PE CLUSTER KIT V3_Box 2_RGT2020137/RGT2158708, SBS reagents_SBS box 1_RGT2120666/RGT2167122, SBS reagents_SBS box 2_RGT2176218/REA0266475, SBS reagents_TRUSEQ MULTIPLEX_RGT2090581/REA0207987		703279	RNA sequencing result	SDY301_EXP13728_RNA_seq.703279.tsv	SDY301_EXP13728_RNA_seq.tsv
SUB122747	Homo sapiens	Black or African American		Not Hispanic or Latino		Male	Age at enrollment		40	Years	Healthy	ARM2107	AIRFV 2012-13	SDY301	Systems Biology Approach to Analysis of 2012-13 TIV Fluzone Influenza Vaccine Response in Healthy Individuals (see companion studies SDY74, SDY296)	BS721045			Other		0	Days	Time of initial vaccine administration			PV2143	1	EXP13728	ES789806		OTHER	SDY-300_C2_NONE	ESR12499, ESR12500, ESR12501, ESR12502, ESR12503, ESR12504, ESR12505, ESR12506, ESR12507, ESR12508, ESR12509	TRUSEQ RNA SAMPLE PREP KIT V2_Box A, TRUSEQ RNA SAMPLE PREP KIT V2_Box 1, TRUSEQ RNA SAMPLE PREP KIT V2_Box 2_8441530/8527616 combined, TRUSEQ RNA SAMPLE PREP KIT V2_PCR Box, Cluster generation_Reagent_GA2001014-PE3/GA2158702-PE3, Cluster generation_Flow cell_COUMKACXX/D16B4ACXX, Cluster generation_Manifold, TRUSEQ PE CLUSTER KIT V3_Box 2_RGT2020137/RGT2158708, SBS reagents_SBS box 1_RGT2120666/RGT2167122, SBS reagents_SBS box 2_RGT2176218/REA0266475, SBS reagents_TRUSEQ MULTIPLEX_RGT2090581/REA0207987		703279	RNA sequencing result	SDY301_EXP13728_RNA_seq.703279.tsv	SDY301_EXP13728_RNA_seq.tsv
SUB122748	Homo sapiens	Black or African American		Not Hispanic or Latino		Male	Age at enrollment		24	Years	Healthy	ARM2107	AIRFV 2012-13	SDY301	Systems Biology Approach to Analysis of 2012-13 TIV Fluzone Influenza Vaccine Response in Healthy Individuals (see companion studies SDY74, SDY296)	BS720965			Other		0	Days	Time of initial vaccine administration			PV2143	1	EXP13728	ES789726		OTHER	SDY-300_C2_NONE	ESR12499, ESR12500, ESR12501, ESR12502, ESR12503, ESR12504, ESR12505, ESR12506, ESR12507, ESR12508, ESR12509	TRUSEQ RNA SAMPLE PREP KIT V2_Box A, TRUSEQ RNA SAMPLE PREP KIT V2_Box 1, TRUSEQ RNA SAMPLE PREP KIT V2_Box 2_8441530/8527616 combined, TRUSEQ RNA SAMPLE PREP KIT V2_PCR Box, Cluster generation_Reagent_GA2001014-PE3/GA2158702-PE3, Cluster generation_Flow cell_COUMKACXX/D16B4ACXX, Cluster generation_Manifold, TRUSEQ PE CLUSTER KIT V3_Box 2_RGT2020137/RGT2158708, SBS reagents_SBS box 1_RGT2120666/RGT2167122, SBS reagents_SBS box 2_RGT2176218/REA0266475, SBS reagents_TRUSEQ MULTIPLEX_RGT2090581/REA0207987		703279	RNA sequencing result	SDY301_EXP13728_RNA_seq.703279.tsv	SDY301_EXP13728_RNA_seq.tsv
SUB122748	Homo sapiens	Black or African American		Not Hispanic or Latino		Male	Age at enrollment		24	Years	Healthy	ARM2107	AIRFV 2012-13	SDY301	Systems Biology Approach to Analysis of 2012-13 TIV Fluzone Influenza Vaccine Response in Healthy Individuals (see companion studies SDY74, SDY296)	BS720990			Other		0	Days	Time of initial vaccine administration			PV2143	1	EXP13728	ES789751		OTHER	SDY-300_C2_NONE	ESR12499, ESR12500, ESR12501, ESR12502, ESR12503, ESR12504, ESR12505, ESR12506, ESR12507, ESR12508, ESR12509	TRUSEQ RNA SAMPLE PREP KIT V2_Box A, TRUSEQ RNA SAMPLE PREP KIT V2_Box 1, TRUSEQ RNA SAMPLE PREP KIT V2_Box 2_8441530/8527616 combined, TRUSEQ RNA SAMPLE PREP KIT V2_PCR Box, Cluster generation_Reagent_GA2001014-PE3/GA2158702-PE3, Cluster generation_Flow cell_COUMKACXX/D16B4ACXX, Cluster generation_Manifold, TRUSEQ PE CLUSTER KIT V3_Box 2_RGT2020137/RGT2158708, SBS reagents_SBS box 1_RGT2120666/RGT2167122, SBS reagents_SBS box 2_RGT2176218/REA0266475, SBS reagents_TRUSEQ MULTIPLEX_RGT2090581/REA0207987		703279	RNA sequencing result	SDY301_EXP13728_RNA_seq.703279.tsv	SDY301_EXP13728_RNA_seq.tsv
SUB122748	Homo sapiens	Black or African American		Not Hispanic or Latino		Male	Age at enrollment		24	Years	Healthy	ARM2107	AIRFV 2012-13	SDY301	Systems Biology Approach to Analysis of 2012-13 TIV Fluzone Influenza Vaccine Response in Healthy Individuals (see companion studies SDY74, SDY296)	BS721018			Other		0	Days	Time of initial vaccine administration			PV2143	1	EXP13728	ES789779		OTHER	SDY-300_C2_NONE	ESR12499, ESR12500, ESR12501, ESR12502, ESR12503, ESR12504, ESR12505, ESR12506, ESR12507, ESR12508, ESR12509	TRUSEQ RNA SAMPLE PREP KIT V2_Box A, TRUSEQ RNA SAMPLE PREP KIT V2_Box 1, TRUSEQ RNA SAMPLE PREP KIT V2_Box 2_8441530/8527616 combined, TRUSEQ RNA SAMPLE PREP KIT V2_PCR Box, Cluster generation_Reagent_GA2001014-PE3/GA2158702-PE3, Cluster generation_Flow cell_COUMKACXX/D16B4ACXX, Cluster generation_Manifold, TRUSEQ PE CLUSTER KIT V3_Box 2_RGT2020137/RGT2158708, SBS reagents_SBS box 1_RGT2120666/RGT2167122, SBS reagents_SBS box 2_RGT2176218/REA0266475, SBS reagents_TRUSEQ MULTIPLEX_RGT2090581/REA0207987		703279	RNA sequencing result	SDY301_EXP13728_RNA_seq.703279.tsv	SDY301_EXP13728_RNA_seq.tsv
SUB122748	Homo sapiens	Black or African American		Not Hispanic or Latino		Male	Age at enrollment		24	Years	Healthy	ARM2107	AIRFV 2012-13	SDY301	Systems Biology Approach to Analysis of 2012-13 TIV Fluzone Influenza Vaccine Response in Healthy Individuals (see companion studies SDY74, SDY296)	BS721046			Other		0	Days	Time of initial vaccine administration			PV2143	1	EXP13728	ES789807		OTHER	SDY-300_C2_NONE	ESR12499, ESR12500, ESR12501, ESR12502, ESR12503, ESR12504, ESR12505, ESR12506, ESR12507, ESR12508, ESR12509	TRUSEQ RNA SAMPLE PREP KIT V2_Box A, TRUSEQ RNA SAMPLE PREP KIT V2_Box 1, TRUSEQ RNA SAMPLE PREP KIT V2_Box 2_8441530/8527616 combined, TRUSEQ RNA SAMPLE PREP KIT V2_PCR Box, Cluster generation_Reagent_GA2001014-PE3/GA2158702-PE3, Cluster generation_Flow cell_COUMKACXX/D16B4ACXX, Cluster generation_Manifold, TRUSEQ PE CLUSTER KIT V3_Box 2_RGT2020137/RGT2158708, SBS reagents_SBS box 1_RGT2120666/RGT2167122, SBS reagents_SBS box 2_RGT2176218/REA0266475, SBS reagents_TRUSEQ MULTIPLEX_RGT2090581/REA0207987		703279	RNA sequencing result	SDY301_EXP13728_RNA_seq.703279.tsv	SDY301_EXP13728_RNA_seq.tsv
SUB122749	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		21	Years	Healthy	ARM2107	AIRFV 2012-13	SDY301	Systems Biology Approach to Analysis of 2012-13 TIV Fluzone Influenza Vaccine Response in Healthy Individuals (see companion studies SDY74, SDY296)	BS721019			Other		0	Days	Time of initial vaccine administration			PV2143	1	EXP13728	ES789780		OTHER	SDY-300_C2_NONE	ESR12499, ESR12500, ESR12501, ESR12502, ESR12503, ESR12504, ESR12505, ESR12506, ESR12507, ESR12508, ESR12509	TRUSEQ RNA SAMPLE PREP KIT V2_Box A, TRUSEQ RNA SAMPLE PREP KIT V2_Box 1, TRUSEQ RNA SAMPLE PREP KIT V2_Box 2_8441530/8527616 combined, TRUSEQ RNA SAMPLE PREP KIT V2_PCR Box, Cluster generation_Reagent_GA2001014-PE3/GA2158702-PE3, Cluster generation_Flow cell_COUMKACXX/D16B4ACXX, Cluster generation_Manifold, TRUSEQ PE CLUSTER KIT V3_Box 2_RGT2020137/RGT2158708, SBS reagents_SBS box 1_RGT2120666/RGT2167122, SBS reagents_SBS box 2_RGT2176218/REA0266475, SBS reagents_TRUSEQ MULTIPLEX_RGT2090581/REA0207987		703279	RNA sequencing result	SDY301_EXP13728_RNA_seq.703279.tsv	SDY301_EXP13728_RNA_seq.tsv
SUB122749	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		21	Years	Healthy	ARM2107	AIRFV 2012-13	SDY301	Systems Biology Approach to Analysis of 2012-13 TIV Fluzone Influenza Vaccine Response in Healthy Individuals (see companion studies SDY74, SDY296)	BS721047			Other		0	Days	Time of initial vaccine administration			PV2143	1	EXP13728	ES789808		OTHER	SDY-300_C2_NONE	ESR12499, ESR12500, ESR12501, ESR12502, ESR12503, ESR12504, ESR12505, ESR12506, ESR12507, ESR12508, ESR12509	TRUSEQ RNA SAMPLE PREP KIT V2_Box A, TRUSEQ RNA SAMPLE PREP KIT V2_Box 1, TRUSEQ RNA SAMPLE PREP KIT V2_Box 2_8441530/8527616 combined, TRUSEQ RNA SAMPLE PREP KIT V2_PCR Box, Cluster generation_Reagent_GA2001014-PE3/GA2158702-PE3, Cluster generation_Flow cell_COUMKACXX/D16B4ACXX, Cluster generation_Manifold, TRUSEQ PE CLUSTER KIT V3_Box 2_RGT2020137/RGT2158708, SBS reagents_SBS box 1_RGT2120666/RGT2167122, SBS reagents_SBS box 2_RGT2176218/REA0266475, SBS reagents_TRUSEQ MULTIPLEX_RGT2090581/REA0207987		703279	RNA sequencing result	SDY301_EXP13728_RNA_seq.703279.tsv	SDY301_EXP13728_RNA_seq.tsv
SUB122752	Homo sapiens	Black or African American		Not Hispanic or Latino		Female	Age at enrollment		35	Years	Healthy	ARM2107	AIRFV 2012-13	SDY301	Systems Biology Approach to Analysis of 2012-13 TIV Fluzone Influenza Vaccine Response in Healthy Individuals (see companion studies SDY74, SDY296)	BS720966			Other		0	Days	Time of initial vaccine administration			PV2143	1	EXP13728	ES789727		OTHER	SDY-300_C2_NONE	ESR12499, ESR12500, ESR12501, ESR12502, ESR12503, ESR12504, ESR12505, ESR12506, ESR12507, ESR12508, ESR12509	TRUSEQ RNA SAMPLE PREP KIT V2_Box A, TRUSEQ RNA SAMPLE PREP KIT V2_Box 1, TRUSEQ RNA SAMPLE PREP KIT V2_Box 2_8441530/8527616 combined, TRUSEQ RNA SAMPLE PREP KIT V2_PCR Box, Cluster generation_Reagent_GA2001014-PE3/GA2158702-PE3, Cluster generation_Flow cell_COUMKACXX/D16B4ACXX, Cluster generation_Manifold, TRUSEQ PE CLUSTER KIT V3_Box 2_RGT2020137/RGT2158708, SBS reagents_SBS box 1_RGT2120666/RGT2167122, SBS reagents_SBS box 2_RGT2176218/REA0266475, SBS reagents_TRUSEQ MULTIPLEX_RGT2090581/REA0207987		703279	RNA sequencing result	SDY301_EXP13728_RNA_seq.703279.tsv	SDY301_EXP13728_RNA_seq.tsv
SUB122752	Homo sapiens	Black or African American		Not Hispanic or Latino		Female	Age at enrollment		35	Years	Healthy	ARM2107	AIRFV 2012-13	SDY301	Systems Biology Approach to Analysis of 2012-13 TIV Fluzone Influenza Vaccine Response in Healthy Individuals (see companion studies SDY74, SDY296)	BS720991			Other		0	Days	Time of initial vaccine administration			PV2143	1	EXP13728	ES789752		OTHER	SDY-300_C2_NONE	ESR12499, ESR12500, ESR12501, ESR12502, ESR12503, ESR12504, ESR12505, ESR12506, ESR12507, ESR12508, ESR12509	TRUSEQ RNA SAMPLE PREP KIT V2_Box A, TRUSEQ RNA SAMPLE PREP KIT V2_Box 1, TRUSEQ RNA SAMPLE PREP KIT V2_Box 2_8441530/8527616 combined, TRUSEQ RNA SAMPLE PREP KIT V2_PCR Box, Cluster generation_Reagent_GA2001014-PE3/GA2158702-PE3, Cluster generation_Flow cell_COUMKACXX/D16B4ACXX, Cluster generation_Manifold, TRUSEQ PE CLUSTER KIT V3_Box 2_RGT2020137/RGT2158708, SBS reagents_SBS box 1_RGT2120666/RGT2167122, SBS reagents_SBS box 2_RGT2176218/REA0266475, SBS reagents_TRUSEQ MULTIPLEX_RGT2090581/REA0207987		703279	RNA sequencing result	SDY301_EXP13728_RNA_seq.703279.tsv	SDY301_EXP13728_RNA_seq.tsv
SUB122752	Homo sapiens	Black or African American		Not Hispanic or Latino		Female	Age at enrollment		35	Years	Healthy	ARM2107	AIRFV 2012-13	SDY301	Systems Biology Approach to Analysis of 2012-13 TIV Fluzone Influenza Vaccine Response in Healthy Individuals (see companion studies SDY74, SDY296)	BS721020			Other		0	Days	Time of initial vaccine administration			PV2143	1	EXP13728	ES789781		OTHER	SDY-300_C2_NONE	ESR12499, ESR12500, ESR12501, ESR12502, ESR12503, ESR12504, ESR12505, ESR12506, ESR12507, ESR12508, ESR12509	TRUSEQ RNA SAMPLE PREP KIT V2_Box A, TRUSEQ RNA SAMPLE PREP KIT V2_Box 1, TRUSEQ RNA SAMPLE PREP KIT V2_Box 2_8441530/8527616 combined, TRUSEQ RNA SAMPLE PREP KIT V2_PCR Box, Cluster generation_Reagent_GA2001014-PE3/GA2158702-PE3, Cluster generation_Flow cell_COUMKACXX/D16B4ACXX, Cluster generation_Manifold, TRUSEQ PE CLUSTER KIT V3_Box 2_RGT2020137/RGT2158708, SBS reagents_SBS box 1_RGT2120666/RGT2167122, SBS reagents_SBS box 2_RGT2176218/REA0266475, SBS reagents_TRUSEQ MULTIPLEX_RGT2090581/REA0207987		703279	RNA sequencing result	SDY301_EXP13728_RNA_seq.703279.tsv	SDY301_EXP13728_RNA_seq.tsv
SUB122752	Homo sapiens	Black or African American		Not Hispanic or Latino		Female	Age at enrollment		35	Years	Healthy	ARM2107	AIRFV 2012-13	SDY301	Systems Biology Approach to Analysis of 2012-13 TIV Fluzone Influenza Vaccine Response in Healthy Individuals (see companion studies SDY74, SDY296)	BS721048			Other		0	Days	Time of initial vaccine administration			PV2143	1	EXP13728	ES789809		OTHER	SDY-300_C2_NONE	ESR12499, ESR12500, ESR12501, ESR12502, ESR12503, ESR12504, ESR12505, ESR12506, ESR12507, ESR12508, ESR12509	TRUSEQ RNA SAMPLE PREP KIT V2_Box A, TRUSEQ RNA SAMPLE PREP KIT V2_Box 1, TRUSEQ RNA SAMPLE PREP KIT V2_Box 2_8441530/8527616 combined, TRUSEQ RNA SAMPLE PREP KIT V2_PCR Box, Cluster generation_Reagent_GA2001014-PE3/GA2158702-PE3, Cluster generation_Flow cell_COUMKACXX/D16B4ACXX, Cluster generation_Manifold, TRUSEQ PE CLUSTER KIT V3_Box 2_RGT2020137/RGT2158708, SBS reagents_SBS box 1_RGT2120666/RGT2167122, SBS reagents_SBS box 2_RGT2176218/REA0266475, SBS reagents_TRUSEQ MULTIPLEX_RGT2090581/REA0207987		703279	RNA sequencing result	SDY301_EXP13728_RNA_seq.703279.tsv	SDY301_EXP13728_RNA_seq.tsv
SUB122753	Homo sapiens	Black or African American		Not Hispanic or Latino		Female	Age at enrollment		37	Years	Healthy	ARM2107	AIRFV 2012-13	SDY301	Systems Biology Approach to Analysis of 2012-13 TIV Fluzone Influenza Vaccine Response in Healthy Individuals (see companion studies SDY74, SDY296)	BS721064			Other		0	Days	Time of initial vaccine administration			PV2143	1	EXP13728	ES789825		OTHER	SDY-300_C2_NONE	ESR12499, ESR12500, ESR12501, ESR12502, ESR12503, ESR12504, ESR12505, ESR12506, ESR12507, ESR12508, ESR12509	TRUSEQ RNA SAMPLE PREP KIT V2_Box A, TRUSEQ RNA SAMPLE PREP KIT V2_Box 1, TRUSEQ RNA SAMPLE PREP KIT V2_Box 2_8441530/8527616 combined, TRUSEQ RNA SAMPLE PREP KIT V2_PCR Box, Cluster generation_Reagent_GA2001014-PE3/GA2158702-PE3, Cluster generation_Flow cell_COUMKACXX/D16B4ACXX, Cluster generation_Manifold, TRUSEQ PE CLUSTER KIT V3_Box 2_RGT2020137/RGT2158708, SBS reagents_SBS box 1_RGT2120666/RGT2167122, SBS reagents_SBS box 2_RGT2176218/REA0266475, SBS reagents_TRUSEQ MULTIPLEX_RGT2090581/REA0207987		703279	RNA sequencing result	SDY301_EXP13728_RNA_seq.703279.tsv	SDY301_EXP13728_RNA_seq.tsv
SUB133802	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		51	Years	Healthy	ARM2107	AIRFV 2012-13	SDY301	Systems Biology Approach to Analysis of 2012-13 TIV Fluzone Influenza Vaccine Response in Healthy Individuals (see companion studies SDY74, SDY296)	BS720969			Other		0	Days	Time of initial vaccine administration			PV2143	1	EXP13728	ES789730		OTHER	SDY-300_C2_NONE	ESR12499, ESR12500, ESR12501, ESR12502, ESR12503, ESR12504, ESR12505, ESR12506, ESR12507, ESR12508, ESR12509	TRUSEQ RNA SAMPLE PREP KIT V2_Box A, TRUSEQ RNA SAMPLE PREP KIT V2_Box 1, TRUSEQ RNA SAMPLE PREP KIT V2_Box 2_8441530/8527616 combined, TRUSEQ RNA SAMPLE PREP KIT V2_PCR Box, Cluster generation_Reagent_GA2001014-PE3/GA2158702-PE3, Cluster generation_Flow cell_COUMKACXX/D16B4ACXX, Cluster generation_Manifold, TRUSEQ PE CLUSTER KIT V3_Box 2_RGT2020137/RGT2158708, SBS reagents_SBS box 1_RGT2120666/RGT2167122, SBS reagents_SBS box 2_RGT2176218/REA0266475, SBS reagents_TRUSEQ MULTIPLEX_RGT2090581/REA0207987		703279	RNA sequencing result	SDY301_EXP13728_RNA_seq.703279.tsv	SDY301_EXP13728_RNA_seq.tsv
SUB133802	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		51	Years	Healthy	ARM2107	AIRFV 2012-13	SDY301	Systems Biology Approach to Analysis of 2012-13 TIV Fluzone Influenza Vaccine Response in Healthy Individuals (see companion studies SDY74, SDY296)	BS720994			Other		0	Days	Time of initial vaccine administration			PV2143	1	EXP13728	ES789755		OTHER	SDY-300_C2_NONE	ESR12499, ESR12500, ESR12501, ESR12502, ESR12503, ESR12504, ESR12505, ESR12506, ESR12507, ESR12508, ESR12509	TRUSEQ RNA SAMPLE PREP KIT V2_Box A, TRUSEQ RNA SAMPLE PREP KIT V2_Box 1, TRUSEQ RNA SAMPLE PREP KIT V2_Box 2_8441530/8527616 combined, TRUSEQ RNA SAMPLE PREP KIT V2_PCR Box, Cluster generation_Reagent_GA2001014-PE3/GA2158702-PE3, Cluster generation_Flow cell_COUMKACXX/D16B4ACXX, Cluster generation_Manifold, TRUSEQ PE CLUSTER KIT V3_Box 2_RGT2020137/RGT2158708, SBS reagents_SBS box 1_RGT2120666/RGT2167122, SBS reagents_SBS box 2_RGT2176218/REA0266475, SBS reagents_TRUSEQ MULTIPLEX_RGT2090581/REA0207987		703279	RNA sequencing result	SDY301_EXP13728_RNA_seq.703279.tsv	SDY301_EXP13728_RNA_seq.tsv
SUB133802	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		51	Years	Healthy	ARM2107	AIRFV 2012-13	SDY301	Systems Biology Approach to Analysis of 2012-13 TIV Fluzone Influenza Vaccine Response in Healthy Individuals (see companion studies SDY74, SDY296)	BS721023			Other		0	Days	Time of initial vaccine administration			PV2143	1	EXP13728	ES789784		OTHER	SDY-300_C2_NONE	ESR12499, ESR12500, ESR12501, ESR12502, ESR12503, ESR12504, ESR12505, ESR12506, ESR12507, ESR12508, ESR12509	TRUSEQ RNA SAMPLE PREP KIT V2_Box A, TRUSEQ RNA SAMPLE PREP KIT V2_Box 1, TRUSEQ RNA SAMPLE PREP KIT V2_Box 2_8441530/8527616 combined, TRUSEQ RNA SAMPLE PREP KIT V2_PCR Box, Cluster generation_Reagent_GA2001014-PE3/GA2158702-PE3, Cluster generation_Flow cell_COUMKACXX/D16B4ACXX, Cluster generation_Manifold, TRUSEQ PE CLUSTER KIT V3_Box 2_RGT2020137/RGT2158708, SBS reagents_SBS box 1_RGT2120666/RGT2167122, SBS reagents_SBS box 2_RGT2176218/REA0266475, SBS reagents_TRUSEQ MULTIPLEX_RGT2090581/REA0207987		703279	RNA sequencing result	SDY301_EXP13728_RNA_seq.703279.tsv	SDY301_EXP13728_RNA_seq.tsv
SUB133802	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		51	Years	Healthy	ARM2107	AIRFV 2012-13	SDY301	Systems Biology Approach to Analysis of 2012-13 TIV Fluzone Influenza Vaccine Response in Healthy Individuals (see companion studies SDY74, SDY296)	BS721051			Other		0	Days	Time of initial vaccine administration			PV2143	1	EXP13728	ES789812		OTHER	SDY-300_C2_NONE	ESR12499, ESR12500, ESR12501, ESR12502, ESR12503, ESR12504, ESR12505, ESR12506, ESR12507, ESR12508, ESR12509	TRUSEQ RNA SAMPLE PREP KIT V2_Box A, TRUSEQ RNA SAMPLE PREP KIT V2_Box 1, TRUSEQ RNA SAMPLE PREP KIT V2_Box 2_8441530/8527616 combined, TRUSEQ RNA SAMPLE PREP KIT V2_PCR Box, Cluster generation_Reagent_GA2001014-PE3/GA2158702-PE3, Cluster generation_Flow cell_COUMKACXX/D16B4ACXX, Cluster generation_Manifold, TRUSEQ PE CLUSTER KIT V3_Box 2_RGT2020137/RGT2158708, SBS reagents_SBS box 1_RGT2120666/RGT2167122, SBS reagents_SBS box 2_RGT2176218/REA0266475, SBS reagents_TRUSEQ MULTIPLEX_RGT2090581/REA0207987		703279	RNA sequencing result	SDY301_EXP13728_RNA_seq.703279.tsv	SDY301_EXP13728_RNA_seq.tsv
SUB133803	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		54	Years	Healthy	ARM2107	AIRFV 2012-13	SDY301	Systems Biology Approach to Analysis of 2012-13 TIV Fluzone Influenza Vaccine Response in Healthy Individuals (see companion studies SDY74, SDY296)	BS720970			Other		0	Days	Time of initial vaccine administration			PV2143	1	EXP13728	ES789731		OTHER	SDY-300_C2_NONE	ESR12499, ESR12500, ESR12501, ESR12502, ESR12503, ESR12504, ESR12505, ESR12506, ESR12507, ESR12508, ESR12509	TRUSEQ RNA SAMPLE PREP KIT V2_Box A, TRUSEQ RNA SAMPLE PREP KIT V2_Box 1, TRUSEQ RNA SAMPLE PREP KIT V2_Box 2_8441530/8527616 combined, TRUSEQ RNA SAMPLE PREP KIT V2_PCR Box, Cluster generation_Reagent_GA2001014-PE3/GA2158702-PE3, Cluster generation_Flow cell_COUMKACXX/D16B4ACXX, Cluster generation_Manifold, TRUSEQ PE CLUSTER KIT V3_Box 2_RGT2020137/RGT2158708, SBS reagents_SBS box 1_RGT2120666/RGT2167122, SBS reagents_SBS box 2_RGT2176218/REA0266475, SBS reagents_TRUSEQ MULTIPLEX_RGT2090581/REA0207987		703279	RNA sequencing result	SDY301_EXP13728_RNA_seq.703279.tsv	SDY301_EXP13728_RNA_seq.tsv
SUB133803	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		54	Years	Healthy	ARM2107	AIRFV 2012-13	SDY301	Systems Biology Approach to Analysis of 2012-13 TIV Fluzone Influenza Vaccine Response in Healthy Individuals (see companion studies SDY74, SDY296)	BS720995			Other		0	Days	Time of initial vaccine administration			PV2143	1	EXP13728	ES789756		OTHER	SDY-300_C2_NONE	ESR12499, ESR12500, ESR12501, ESR12502, ESR12503, ESR12504, ESR12505, ESR12506, ESR12507, ESR12508, ESR12509	TRUSEQ RNA SAMPLE PREP KIT V2_Box A, TRUSEQ RNA SAMPLE PREP KIT V2_Box 1, TRUSEQ RNA SAMPLE PREP KIT V2_Box 2_8441530/8527616 combined, TRUSEQ RNA SAMPLE PREP KIT V2_PCR Box, Cluster generation_Reagent_GA2001014-PE3/GA2158702-PE3, Cluster generation_Flow cell_COUMKACXX/D16B4ACXX, Cluster generation_Manifold, TRUSEQ PE CLUSTER KIT V3_Box 2_RGT2020137/RGT2158708, SBS reagents_SBS box 1_RGT2120666/RGT2167122, SBS reagents_SBS box 2_RGT2176218/REA0266475, SBS reagents_TRUSEQ MULTIPLEX_RGT2090581/REA0207987		703279	RNA sequencing result	SDY301_EXP13728_RNA_seq.703279.tsv	SDY301_EXP13728_RNA_seq.tsv
SUB133803	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		54	Years	Healthy	ARM2107	AIRFV 2012-13	SDY301	Systems Biology Approach to Analysis of 2012-13 TIV Fluzone Influenza Vaccine Response in Healthy Individuals (see companion studies SDY74, SDY296)	BS721024			Other		0	Days	Time of initial vaccine administration			PV2143	1	EXP13728	ES789785		OTHER	SDY-300_C2_NONE	ESR12499, ESR12500, ESR12501, ESR12502, ESR12503, ESR12504, ESR12505, ESR12506, ESR12507, ESR12508, ESR12509	TRUSEQ RNA SAMPLE PREP KIT V2_Box A, TRUSEQ RNA SAMPLE PREP KIT V2_Box 1, TRUSEQ RNA SAMPLE PREP KIT V2_Box 2_8441530/8527616 combined, TRUSEQ RNA SAMPLE PREP KIT V2_PCR Box, Cluster generation_Reagent_GA2001014-PE3/GA2158702-PE3, Cluster generation_Flow cell_COUMKACXX/D16B4ACXX, Cluster generation_Manifold, TRUSEQ PE CLUSTER KIT V3_Box 2_RGT2020137/RGT2158708, SBS reagents_SBS box 1_RGT2120666/RGT2167122, SBS reagents_SBS box 2_RGT2176218/REA0266475, SBS reagents_TRUSEQ MULTIPLEX_RGT2090581/REA0207987		703279	RNA sequencing result	SDY301_EXP13728_RNA_seq.703279.tsv	SDY301_EXP13728_RNA_seq.tsv
SUB133803	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		54	Years	Healthy	ARM2107	AIRFV 2012-13	SDY301	Systems Biology Approach to Analysis of 2012-13 TIV Fluzone Influenza Vaccine Response in Healthy Individuals (see companion studies SDY74, SDY296)	BS721052			Other		0	Days	Time of initial vaccine administration			PV2143	1	EXP13728	ES789813		OTHER	SDY-300_C2_NONE	ESR12499, ESR12500, ESR12501, ESR12502, ESR12503, ESR12504, ESR12505, ESR12506, ESR12507, ESR12508, ESR12509	TRUSEQ RNA SAMPLE PREP KIT V2_Box A, TRUSEQ RNA SAMPLE PREP KIT V2_Box 1, TRUSEQ RNA SAMPLE PREP KIT V2_Box 2_8441530/8527616 combined, TRUSEQ RNA SAMPLE PREP KIT V2_PCR Box, Cluster generation_Reagent_GA2001014-PE3/GA2158702-PE3, Cluster generation_Flow cell_COUMKACXX/D16B4ACXX, Cluster generation_Manifold, TRUSEQ PE CLUSTER KIT V3_Box 2_RGT2020137/RGT2158708, SBS reagents_SBS box 1_RGT2120666/RGT2167122, SBS reagents_SBS box 2_RGT2176218/REA0266475, SBS reagents_TRUSEQ MULTIPLEX_RGT2090581/REA0207987		703279	RNA sequencing result	SDY301_EXP13728_RNA_seq.703279.tsv	SDY301_EXP13728_RNA_seq.tsv
SUB133804	Homo sapiens	Black or African American		Not Hispanic or Latino		Male	Age at enrollment		26	Years	Healthy	ARM2107	AIRFV 2012-13	SDY301	Systems Biology Approach to Analysis of 2012-13 TIV Fluzone Influenza Vaccine Response in Healthy Individuals (see companion studies SDY74, SDY296)	BS720971			Other		0	Days	Time of initial vaccine administration			PV2143	1	EXP13728	ES789732		OTHER	SDY-300_C2_NONE	ESR12499, ESR12500, ESR12501, ESR12502, ESR12503, ESR12504, ESR12505, ESR12506, ESR12507, ESR12508, ESR12509	TRUSEQ RNA SAMPLE PREP KIT V2_Box A, TRUSEQ RNA SAMPLE PREP KIT V2_Box 1, TRUSEQ RNA SAMPLE PREP KIT V2_Box 2_8441530/8527616 combined, TRUSEQ RNA SAMPLE PREP KIT V2_PCR Box, Cluster generation_Reagent_GA2001014-PE3/GA2158702-PE3, Cluster generation_Flow cell_COUMKACXX/D16B4ACXX, Cluster generation_Manifold, TRUSEQ PE CLUSTER KIT V3_Box 2_RGT2020137/RGT2158708, SBS reagents_SBS box 1_RGT2120666/RGT2167122, SBS reagents_SBS box 2_RGT2176218/REA0266475, SBS reagents_TRUSEQ MULTIPLEX_RGT2090581/REA0207987		703279	RNA sequencing result	SDY301_EXP13728_RNA_seq.703279.tsv	SDY301_EXP13728_RNA_seq.tsv
SUB133804	Homo sapiens	Black or African American		Not Hispanic or Latino		Male	Age at enrollment		26	Years	Healthy	ARM2107	AIRFV 2012-13	SDY301	Systems Biology Approach to Analysis of 2012-13 TIV Fluzone Influenza Vaccine Response in Healthy Individuals (see companion studies SDY74, SDY296)	BS720996			Other		0	Days	Time of initial vaccine administration			PV2143	1	EXP13728	ES789757		OTHER	SDY-300_C2_NONE	ESR12499, ESR12500, ESR12501, ESR12502, ESR12503, ESR12504, ESR12505, ESR12506, ESR12507, ESR12508, ESR12509	TRUSEQ RNA SAMPLE PREP KIT V2_Box A, TRUSEQ RNA SAMPLE PREP KIT V2_Box 1, TRUSEQ RNA SAMPLE PREP KIT V2_Box 2_8441530/8527616 combined, TRUSEQ RNA SAMPLE PREP KIT V2_PCR Box, Cluster generation_Reagent_GA2001014-PE3/GA2158702-PE3, Cluster generation_Flow cell_COUMKACXX/D16B4ACXX, Cluster generation_Manifold, TRUSEQ PE CLUSTER KIT V3_Box 2_RGT2020137/RGT2158708, SBS reagents_SBS box 1_RGT2120666/RGT2167122, SBS reagents_SBS box 2_RGT2176218/REA0266475, SBS reagents_TRUSEQ MULTIPLEX_RGT2090581/REA0207987		703279	RNA sequencing result	SDY301_EXP13728_RNA_seq.703279.tsv	SDY301_EXP13728_RNA_seq.tsv
SUB133804	Homo sapiens	Black or African American		Not Hispanic or Latino		Male	Age at enrollment		26	Years	Healthy	ARM2107	AIRFV 2012-13	SDY301	Systems Biology Approach to Analysis of 2012-13 TIV Fluzone Influenza Vaccine Response in Healthy Individuals (see companion studies SDY74, SDY296)	BS721025			Other		0	Days	Time of initial vaccine administration			PV2143	1	EXP13728	ES789786		OTHER	SDY-300_C2_NONE	ESR12499, ESR12500, ESR12501, ESR12502, ESR12503, ESR12504, ESR12505, ESR12506, ESR12507, ESR12508, ESR12509	TRUSEQ RNA SAMPLE PREP KIT V2_Box A, TRUSEQ RNA SAMPLE PREP KIT V2_Box 1, TRUSEQ RNA SAMPLE PREP KIT V2_Box 2_8441530/8527616 combined, TRUSEQ RNA SAMPLE PREP KIT V2_PCR Box, Cluster generation_Reagent_GA2001014-PE3/GA2158702-PE3, Cluster generation_Flow cell_COUMKACXX/D16B4ACXX, Cluster generation_Manifold, TRUSEQ PE CLUSTER KIT V3_Box 2_RGT2020137/RGT2158708, SBS reagents_SBS box 1_RGT2120666/RGT2167122, SBS reagents_SBS box 2_RGT2176218/REA0266475, SBS reagents_TRUSEQ MULTIPLEX_RGT2090581/REA0207987		703279	RNA sequencing result	SDY301_EXP13728_RNA_seq.703279.tsv	SDY301_EXP13728_RNA_seq.tsv
SUB133804	Homo sapiens	Black or African American		Not Hispanic or Latino		Male	Age at enrollment		26	Years	Healthy	ARM2107	AIRFV 2012-13	SDY301	Systems Biology Approach to Analysis of 2012-13 TIV Fluzone Influenza Vaccine Response in Healthy Individuals (see companion studies SDY74, SDY296)	BS721053			Other		0	Days	Time of initial vaccine administration			PV2143	1	EXP13728	ES789814		OTHER	SDY-300_C2_NONE	ESR12499, ESR12500, ESR12501, ESR12502, ESR12503, ESR12504, ESR12505, ESR12506, ESR12507, ESR12508, ESR12509	TRUSEQ RNA SAMPLE PREP KIT V2_Box A, TRUSEQ RNA SAMPLE PREP KIT V2_Box 1, TRUSEQ RNA SAMPLE PREP KIT V2_Box 2_8441530/8527616 combined, TRUSEQ RNA SAMPLE PREP KIT V2_PCR Box, Cluster generation_Reagent_GA2001014-PE3/GA2158702-PE3, Cluster generation_Flow cell_COUMKACXX/D16B4ACXX, Cluster generation_Manifold, TRUSEQ PE CLUSTER KIT V3_Box 2_RGT2020137/RGT2158708, SBS reagents_SBS box 1_RGT2120666/RGT2167122, SBS reagents_SBS box 2_RGT2176218/REA0266475, SBS reagents_TRUSEQ MULTIPLEX_RGT2090581/REA0207987		703279	RNA sequencing result	SDY301_EXP13728_RNA_seq.703279.tsv	SDY301_EXP13728_RNA_seq.tsv
SUB133805	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		24	Years	Healthy	ARM2107	AIRFV 2012-13	SDY301	Systems Biology Approach to Analysis of 2012-13 TIV Fluzone Influenza Vaccine Response in Healthy Individuals (see companion studies SDY74, SDY296)	BS720972			Other		0	Days	Time of initial vaccine administration			PV2143	1	EXP13728	ES789733		OTHER	SDY-300_C2_NONE	ESR12499, ESR12500, ESR12501, ESR12502, ESR12503, ESR12504, ESR12505, ESR12506, ESR12507, ESR12508, ESR12509	TRUSEQ RNA SAMPLE PREP KIT V2_Box A, TRUSEQ RNA SAMPLE PREP KIT V2_Box 1, TRUSEQ RNA SAMPLE PREP KIT V2_Box 2_8441530/8527616 combined, TRUSEQ RNA SAMPLE PREP KIT V2_PCR Box, Cluster generation_Reagent_GA2001014-PE3/GA2158702-PE3, Cluster generation_Flow cell_COUMKACXX/D16B4ACXX, Cluster generation_Manifold, TRUSEQ PE CLUSTER KIT V3_Box 2_RGT2020137/RGT2158708, SBS reagents_SBS box 1_RGT2120666/RGT2167122, SBS reagents_SBS box 2_RGT2176218/REA0266475, SBS reagents_TRUSEQ MULTIPLEX_RGT2090581/REA0207987		703279	RNA sequencing result	SDY301_EXP13728_RNA_seq.703279.tsv	SDY301_EXP13728_RNA_seq.tsv
SUB133805	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		24	Years	Healthy	ARM2107	AIRFV 2012-13	SDY301	Systems Biology Approach to Analysis of 2012-13 TIV Fluzone Influenza Vaccine Response in Healthy Individuals (see companion studies SDY74, SDY296)	BS720997			Other		0	Days	Time of initial vaccine administration			PV2143	1	EXP13728	ES789758		OTHER	SDY-300_C2_NONE	ESR12499, ESR12500, ESR12501, ESR12502, ESR12503, ESR12504, ESR12505, ESR12506, ESR12507, ESR12508, ESR12509	TRUSEQ RNA SAMPLE PREP KIT V2_Box A, TRUSEQ RNA SAMPLE PREP KIT V2_Box 1, TRUSEQ RNA SAMPLE PREP KIT V2_Box 2_8441530/8527616 combined, TRUSEQ RNA SAMPLE PREP KIT V2_PCR Box, Cluster generation_Reagent_GA2001014-PE3/GA2158702-PE3, Cluster generation_Flow cell_COUMKACXX/D16B4ACXX, Cluster generation_Manifold, TRUSEQ PE CLUSTER KIT V3_Box 2_RGT2020137/RGT2158708, SBS reagents_SBS box 1_RGT2120666/RGT2167122, SBS reagents_SBS box 2_RGT2176218/REA0266475, SBS reagents_TRUSEQ MULTIPLEX_RGT2090581/REA0207987		703279	RNA sequencing result	SDY301_EXP13728_RNA_seq.703279.tsv	SDY301_EXP13728_RNA_seq.tsv
SUB133805	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		24	Years	Healthy	ARM2107	AIRFV 2012-13	SDY301	Systems Biology Approach to Analysis of 2012-13 TIV Fluzone Influenza Vaccine Response in Healthy Individuals (see companion studies SDY74, SDY296)	BS721026			Other		0	Days	Time of initial vaccine administration			PV2143	1	EXP13728	ES789787		OTHER	SDY-300_C2_NONE	ESR12499, ESR12500, ESR12501, ESR12502, ESR12503, ESR12504, ESR12505, ESR12506, ESR12507, ESR12508, ESR12509	TRUSEQ RNA SAMPLE PREP KIT V2_Box A, TRUSEQ RNA SAMPLE PREP KIT V2_Box 1, TRUSEQ RNA SAMPLE PREP KIT V2_Box 2_8441530/8527616 combined, TRUSEQ RNA SAMPLE PREP KIT V2_PCR Box, Cluster generation_Reagent_GA2001014-PE3/GA2158702-PE3, Cluster generation_Flow cell_COUMKACXX/D16B4ACXX, Cluster generation_Manifold, TRUSEQ PE CLUSTER KIT V3_Box 2_RGT2020137/RGT2158708, SBS reagents_SBS box 1_RGT2120666/RGT2167122, SBS reagents_SBS box 2_RGT2176218/REA0266475, SBS reagents_TRUSEQ MULTIPLEX_RGT2090581/REA0207987		703279	RNA sequencing result	SDY301_EXP13728_RNA_seq.703279.tsv	SDY301_EXP13728_RNA_seq.tsv
SUB133805	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		24	Years	Healthy	ARM2107	AIRFV 2012-13	SDY301	Systems Biology Approach to Analysis of 2012-13 TIV Fluzone Influenza Vaccine Response in Healthy Individuals (see companion studies SDY74, SDY296)	BS721054			Other		0	Days	Time of initial vaccine administration			PV2143	1	EXP13728	ES789815		OTHER	SDY-300_C2_NONE	ESR12499, ESR12500, ESR12501, ESR12502, ESR12503, ESR12504, ESR12505, ESR12506, ESR12507, ESR12508, ESR12509	TRUSEQ RNA SAMPLE PREP KIT V2_Box A, TRUSEQ RNA SAMPLE PREP KIT V2_Box 1, TRUSEQ RNA SAMPLE PREP KIT V2_Box 2_8441530/8527616 combined, TRUSEQ RNA SAMPLE PREP KIT V2_PCR Box, Cluster generation_Reagent_GA2001014-PE3/GA2158702-PE3, Cluster generation_Flow cell_COUMKACXX/D16B4ACXX, Cluster generation_Manifold, TRUSEQ PE CLUSTER KIT V3_Box 2_RGT2020137/RGT2158708, SBS reagents_SBS box 1_RGT2120666/RGT2167122, SBS reagents_SBS box 2_RGT2176218/REA0266475, SBS reagents_TRUSEQ MULTIPLEX_RGT2090581/REA0207987		703279	RNA sequencing result	SDY301_EXP13728_RNA_seq.703279.tsv	SDY301_EXP13728_RNA_seq.tsv
SUB133806	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		22	Years	Healthy	ARM2107	AIRFV 2012-13	SDY301	Systems Biology Approach to Analysis of 2012-13 TIV Fluzone Influenza Vaccine Response in Healthy Individuals (see companion studies SDY74, SDY296)	BS720973			Other		0	Days	Time of initial vaccine administration			PV2143	1	EXP13728	ES789734		OTHER	SDY-300_C2_NONE	ESR12499, ESR12500, ESR12501, ESR12502, ESR12503, ESR12504, ESR12505, ESR12506, ESR12507, ESR12508, ESR12509	TRUSEQ RNA SAMPLE PREP KIT V2_Box A, TRUSEQ RNA SAMPLE PREP KIT V2_Box 1, TRUSEQ RNA SAMPLE PREP KIT V2_Box 2_8441530/8527616 combined, TRUSEQ RNA SAMPLE PREP KIT V2_PCR Box, Cluster generation_Reagent_GA2001014-PE3/GA2158702-PE3, Cluster generation_Flow cell_COUMKACXX/D16B4ACXX, Cluster generation_Manifold, TRUSEQ PE CLUSTER KIT V3_Box 2_RGT2020137/RGT2158708, SBS reagents_SBS box 1_RGT2120666/RGT2167122, SBS reagents_SBS box 2_RGT2176218/REA0266475, SBS reagents_TRUSEQ MULTIPLEX_RGT2090581/REA0207987		703279	RNA sequencing result	SDY301_EXP13728_RNA_seq.703279.tsv	SDY301_EXP13728_RNA_seq.tsv
SUB133806	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		22	Years	Healthy	ARM2107	AIRFV 2012-13	SDY301	Systems Biology Approach to Analysis of 2012-13 TIV Fluzone Influenza Vaccine Response in Healthy Individuals (see companion studies SDY74, SDY296)	BS720998			Other		0	Days	Time of initial vaccine administration			PV2143	1	EXP13728	ES789759		OTHER	SDY-300_C2_NONE	ESR12499, ESR12500, ESR12501, ESR12502, ESR12503, ESR12504, ESR12505, ESR12506, ESR12507, ESR12508, ESR12509	TRUSEQ RNA SAMPLE PREP KIT V2_Box A, TRUSEQ RNA SAMPLE PREP KIT V2_Box 1, TRUSEQ RNA SAMPLE PREP KIT V2_Box 2_8441530/8527616 combined, TRUSEQ RNA SAMPLE PREP KIT V2_PCR Box, Cluster generation_Reagent_GA2001014-PE3/GA2158702-PE3, Cluster generation_Flow cell_COUMKACXX/D16B4ACXX, Cluster generation_Manifold, TRUSEQ PE CLUSTER KIT V3_Box 2_RGT2020137/RGT2158708, SBS reagents_SBS box 1_RGT2120666/RGT2167122, SBS reagents_SBS box 2_RGT2176218/REA0266475, SBS reagents_TRUSEQ MULTIPLEX_RGT2090581/REA0207987		703279	RNA sequencing result	SDY301_EXP13728_RNA_seq.703279.tsv	SDY301_EXP13728_RNA_seq.tsv
SUB133806	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		22	Years	Healthy	ARM2107	AIRFV 2012-13	SDY301	Systems Biology Approach to Analysis of 2012-13 TIV Fluzone Influenza Vaccine Response in Healthy Individuals (see companion studies SDY74, SDY296)	BS721027			Other		0	Days	Time of initial vaccine administration			PV2143	1	EXP13728	ES789788		OTHER	SDY-300_C2_NONE	ESR12499, ESR12500, ESR12501, ESR12502, ESR12503, ESR12504, ESR12505, ESR12506, ESR12507, ESR12508, ESR12509	TRUSEQ RNA SAMPLE PREP KIT V2_Box A, TRUSEQ RNA SAMPLE PREP KIT V2_Box 1, TRUSEQ RNA SAMPLE PREP KIT V2_Box 2_8441530/8527616 combined, TRUSEQ RNA SAMPLE PREP KIT V2_PCR Box, Cluster generation_Reagent_GA2001014-PE3/GA2158702-PE3, Cluster generation_Flow cell_COUMKACXX/D16B4ACXX, Cluster generation_Manifold, TRUSEQ PE CLUSTER KIT V3_Box 2_RGT2020137/RGT2158708, SBS reagents_SBS box 1_RGT2120666/RGT2167122, SBS reagents_SBS box 2_RGT2176218/REA0266475, SBS reagents_TRUSEQ MULTIPLEX_RGT2090581/REA0207987		703279	RNA sequencing result	SDY301_EXP13728_RNA_seq.703279.tsv	SDY301_EXP13728_RNA_seq.tsv
SUB133806	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		22	Years	Healthy	ARM2107	AIRFV 2012-13	SDY301	Systems Biology Approach to Analysis of 2012-13 TIV Fluzone Influenza Vaccine Response in Healthy Individuals (see companion studies SDY74, SDY296)	BS721055			Other		0	Days	Time of initial vaccine administration			PV2143	1	EXP13728	ES789816		OTHER	SDY-300_C2_NONE	ESR12499, ESR12500, ESR12501, ESR12502, ESR12503, ESR12504, ESR12505, ESR12506, ESR12507, ESR12508, ESR12509	TRUSEQ RNA SAMPLE PREP KIT V2_Box A, TRUSEQ RNA SAMPLE PREP KIT V2_Box 1, TRUSEQ RNA SAMPLE PREP KIT V2_Box 2_8441530/8527616 combined, TRUSEQ RNA SAMPLE PREP KIT V2_PCR Box, Cluster generation_Reagent_GA2001014-PE3/GA2158702-PE3, Cluster generation_Flow cell_COUMKACXX/D16B4ACXX, Cluster generation_Manifold, TRUSEQ PE CLUSTER KIT V3_Box 2_RGT2020137/RGT2158708, SBS reagents_SBS box 1_RGT2120666/RGT2167122, SBS reagents_SBS box 2_RGT2176218/REA0266475, SBS reagents_TRUSEQ MULTIPLEX_RGT2090581/REA0207987		703279	RNA sequencing result	SDY301_EXP13728_RNA_seq.703279.tsv	SDY301_EXP13728_RNA_seq.tsv
SUB133807	Homo sapiens	Black or African American		Not Hispanic or Latino		Female	Age at enrollment		26	Years	Healthy	ARM2107	AIRFV 2012-13	SDY301	Systems Biology Approach to Analysis of 2012-13 TIV Fluzone Influenza Vaccine Response in Healthy Individuals (see companion studies SDY74, SDY296)	BS720974			Other		0	Days	Time of initial vaccine administration			PV2143	1	EXP13728	ES789735		OTHER	SDY-300_C2_NONE	ESR12499, ESR12500, ESR12501, ESR12502, ESR12503, ESR12504, ESR12505, ESR12506, ESR12507, ESR12508, ESR12509	TRUSEQ RNA SAMPLE PREP KIT V2_Box A, TRUSEQ RNA SAMPLE PREP KIT V2_Box 1, TRUSEQ RNA SAMPLE PREP KIT V2_Box 2_8441530/8527616 combined, TRUSEQ RNA SAMPLE PREP KIT V2_PCR Box, Cluster generation_Reagent_GA2001014-PE3/GA2158702-PE3, Cluster generation_Flow cell_COUMKACXX/D16B4ACXX, Cluster generation_Manifold, TRUSEQ PE CLUSTER KIT V3_Box 2_RGT2020137/RGT2158708, SBS reagents_SBS box 1_RGT2120666/RGT2167122, SBS reagents_SBS box 2_RGT2176218/REA0266475, SBS reagents_TRUSEQ MULTIPLEX_RGT2090581/REA0207987		703279	RNA sequencing result	SDY301_EXP13728_RNA_seq.703279.tsv	SDY301_EXP13728_RNA_seq.tsv
SUB133807	Homo sapiens	Black or African American		Not Hispanic or Latino		Female	Age at enrollment		26	Years	Healthy	ARM2107	AIRFV 2012-13	SDY301	Systems Biology Approach to Analysis of 2012-13 TIV Fluzone Influenza Vaccine Response in Healthy Individuals (see companion studies SDY74, SDY296)	BS720999			Other		0	Days	Time of initial vaccine administration			PV2143	1	EXP13728	ES789760		OTHER	SDY-300_C2_NONE	ESR12499, ESR12500, ESR12501, ESR12502, ESR12503, ESR12504, ESR12505, ESR12506, ESR12507, ESR12508, ESR12509	TRUSEQ RNA SAMPLE PREP KIT V2_Box A, TRUSEQ RNA SAMPLE PREP KIT V2_Box 1, TRUSEQ RNA SAMPLE PREP KIT V2_Box 2_8441530/8527616 combined, TRUSEQ RNA SAMPLE PREP KIT V2_PCR Box, Cluster generation_Reagent_GA2001014-PE3/GA2158702-PE3, Cluster generation_Flow cell_COUMKACXX/D16B4ACXX, Cluster generation_Manifold, TRUSEQ PE CLUSTER KIT V3_Box 2_RGT2020137/RGT2158708, SBS reagents_SBS box 1_RGT2120666/RGT2167122, SBS reagents_SBS box 2_RGT2176218/REA0266475, SBS reagents_TRUSEQ MULTIPLEX_RGT2090581/REA0207987		703279	RNA sequencing result	SDY301_EXP13728_RNA_seq.703279.tsv	SDY301_EXP13728_RNA_seq.tsv
SUB133807	Homo sapiens	Black or African American		Not Hispanic or Latino		Female	Age at enrollment		26	Years	Healthy	ARM2107	AIRFV 2012-13	SDY301	Systems Biology Approach to Analysis of 2012-13 TIV Fluzone Influenza Vaccine Response in Healthy Individuals (see companion studies SDY74, SDY296)	BS721028			Other		0	Days	Time of initial vaccine administration			PV2143	1	EXP13728	ES789789		OTHER	SDY-300_C2_NONE	ESR12499, ESR12500, ESR12501, ESR12502, ESR12503, ESR12504, ESR12505, ESR12506, ESR12507, ESR12508, ESR12509	TRUSEQ RNA SAMPLE PREP KIT V2_Box A, TRUSEQ RNA SAMPLE PREP KIT V2_Box 1, TRUSEQ RNA SAMPLE PREP KIT V2_Box 2_8441530/8527616 combined, TRUSEQ RNA SAMPLE PREP KIT V2_PCR Box, Cluster generation_Reagent_GA2001014-PE3/GA2158702-PE3, Cluster generation_Flow cell_COUMKACXX/D16B4ACXX, Cluster generation_Manifold, TRUSEQ PE CLUSTER KIT V3_Box 2_RGT2020137/RGT2158708, SBS reagents_SBS box 1_RGT2120666/RGT2167122, SBS reagents_SBS box 2_RGT2176218/REA0266475, SBS reagents_TRUSEQ MULTIPLEX_RGT2090581/REA0207987		703279	RNA sequencing result	SDY301_EXP13728_RNA_seq.703279.tsv	SDY301_EXP13728_RNA_seq.tsv
SUB133807	Homo sapiens	Black or African American		Not Hispanic or Latino		Female	Age at enrollment		26	Years	Healthy	ARM2107	AIRFV 2012-13	SDY301	Systems Biology Approach to Analysis of 2012-13 TIV Fluzone Influenza Vaccine Response in Healthy Individuals (see companion studies SDY74, SDY296)	BS721056			Other		0	Days	Time of initial vaccine administration			PV2143	1	EXP13728	ES789817		OTHER	SDY-300_C2_NONE	ESR12499, ESR12500, ESR12501, ESR12502, ESR12503, ESR12504, ESR12505, ESR12506, ESR12507, ESR12508, ESR12509	TRUSEQ RNA SAMPLE PREP KIT V2_Box A, TRUSEQ RNA SAMPLE PREP KIT V2_Box 1, TRUSEQ RNA SAMPLE PREP KIT V2_Box 2_8441530/8527616 combined, TRUSEQ RNA SAMPLE PREP KIT V2_PCR Box, Cluster generation_Reagent_GA2001014-PE3/GA2158702-PE3, Cluster generation_Flow cell_COUMKACXX/D16B4ACXX, Cluster generation_Manifold, TRUSEQ PE CLUSTER KIT V3_Box 2_RGT2020137/RGT2158708, SBS reagents_SBS box 1_RGT2120666/RGT2167122, SBS reagents_SBS box 2_RGT2176218/REA0266475, SBS reagents_TRUSEQ MULTIPLEX_RGT2090581/REA0207987		703279	RNA sequencing result	SDY301_EXP13728_RNA_seq.703279.tsv	SDY301_EXP13728_RNA_seq.tsv
SUB133808	Homo sapiens	White		Hispanic or Latino		Female	Age at enrollment		26	Years	Healthy	ARM2107	AIRFV 2012-13	SDY301	Systems Biology Approach to Analysis of 2012-13 TIV Fluzone Influenza Vaccine Response in Healthy Individuals (see companion studies SDY74, SDY296)	BS720975			Other		0	Days	Time of initial vaccine administration			PV2143	1	EXP13728	ES789736		OTHER	SDY-300_C2_NONE	ESR12499, ESR12500, ESR12501, ESR12502, ESR12503, ESR12504, ESR12505, ESR12506, ESR12507, ESR12508, ESR12509	TRUSEQ RNA SAMPLE PREP KIT V2_Box A, TRUSEQ RNA SAMPLE PREP KIT V2_Box 1, TRUSEQ RNA SAMPLE PREP KIT V2_Box 2_8441530/8527616 combined, TRUSEQ RNA SAMPLE PREP KIT V2_PCR Box, Cluster generation_Reagent_GA2001014-PE3/GA2158702-PE3, Cluster generation_Flow cell_COUMKACXX/D16B4ACXX, Cluster generation_Manifold, TRUSEQ PE CLUSTER KIT V3_Box 2_RGT2020137/RGT2158708, SBS reagents_SBS box 1_RGT2120666/RGT2167122, SBS reagents_SBS box 2_RGT2176218/REA0266475, SBS reagents_TRUSEQ MULTIPLEX_RGT2090581/REA0207987		703279	RNA sequencing result	SDY301_EXP13728_RNA_seq.703279.tsv	SDY301_EXP13728_RNA_seq.tsv
SUB133808	Homo sapiens	White		Hispanic or Latino		Female	Age at enrollment		26	Years	Healthy	ARM2107	AIRFV 2012-13	SDY301	Systems Biology Approach to Analysis of 2012-13 TIV Fluzone Influenza Vaccine Response in Healthy Individuals (see companion studies SDY74, SDY296)	BS721000			Other		0	Days	Time of initial vaccine administration			PV2143	1	EXP13728	ES789761		OTHER	SDY-300_C2_NONE	ESR12499, ESR12500, ESR12501, ESR12502, ESR12503, ESR12504, ESR12505, ESR12506, ESR12507, ESR12508, ESR12509	TRUSEQ RNA SAMPLE PREP KIT V2_Box A, TRUSEQ RNA SAMPLE PREP KIT V2_Box 1, TRUSEQ RNA SAMPLE PREP KIT V2_Box 2_8441530/8527616 combined, TRUSEQ RNA SAMPLE PREP KIT V2_PCR Box, Cluster generation_Reagent_GA2001014-PE3/GA2158702-PE3, Cluster generation_Flow cell_COUMKACXX/D16B4ACXX, Cluster generation_Manifold, TRUSEQ PE CLUSTER KIT V3_Box 2_RGT2020137/RGT2158708, SBS reagents_SBS box 1_RGT2120666/RGT2167122, SBS reagents_SBS box 2_RGT2176218/REA0266475, SBS reagents_TRUSEQ MULTIPLEX_RGT2090581/REA0207987		703279	RNA sequencing result	SDY301_EXP13728_RNA_seq.703279.tsv	SDY301_EXP13728_RNA_seq.tsv
SUB133808	Homo sapiens	White		Hispanic or Latino		Female	Age at enrollment		26	Years	Healthy	ARM2107	AIRFV 2012-13	SDY301	Systems Biology Approach to Analysis of 2012-13 TIV Fluzone Influenza Vaccine Response in Healthy Individuals (see companion studies SDY74, SDY296)	BS721029			Other		0	Days	Time of initial vaccine administration			PV2143	1	EXP13728	ES789790		OTHER	SDY-300_C2_NONE	ESR12499, ESR12500, ESR12501, ESR12502, ESR12503, ESR12504, ESR12505, ESR12506, ESR12507, ESR12508, ESR12509	TRUSEQ RNA SAMPLE PREP KIT V2_Box A, TRUSEQ RNA SAMPLE PREP KIT V2_Box 1, TRUSEQ RNA SAMPLE PREP KIT V2_Box 2_8441530/8527616 combined, TRUSEQ RNA SAMPLE PREP KIT V2_PCR Box, Cluster generation_Reagent_GA2001014-PE3/GA2158702-PE3, Cluster generation_Flow cell_COUMKACXX/D16B4ACXX, Cluster generation_Manifold, TRUSEQ PE CLUSTER KIT V3_Box 2_RGT2020137/RGT2158708, SBS reagents_SBS box 1_RGT2120666/RGT2167122, SBS reagents_SBS box 2_RGT2176218/REA0266475, SBS reagents_TRUSEQ MULTIPLEX_RGT2090581/REA0207987		703279	RNA sequencing result	SDY301_EXP13728_RNA_seq.703279.tsv	SDY301_EXP13728_RNA_seq.tsv
SUB133808	Homo sapiens	White		Hispanic or Latino		Female	Age at enrollment		26	Years	Healthy	ARM2107	AIRFV 2012-13	SDY301	Systems Biology Approach to Analysis of 2012-13 TIV Fluzone Influenza Vaccine Response in Healthy Individuals (see companion studies SDY74, SDY296)	BS721057			Other		0	Days	Time of initial vaccine administration			PV2143	1	EXP13728	ES789818		OTHER	SDY-300_C2_NONE	ESR12499, ESR12500, ESR12501, ESR12502, ESR12503, ESR12504, ESR12505, ESR12506, ESR12507, ESR12508, ESR12509	TRUSEQ RNA SAMPLE PREP KIT V2_Box A, TRUSEQ RNA SAMPLE PREP KIT V2_Box 1, TRUSEQ RNA SAMPLE PREP KIT V2_Box 2_8441530/8527616 combined, TRUSEQ RNA SAMPLE PREP KIT V2_PCR Box, Cluster generation_Reagent_GA2001014-PE3/GA2158702-PE3, Cluster generation_Flow cell_COUMKACXX/D16B4ACXX, Cluster generation_Manifold, TRUSEQ PE CLUSTER KIT V3_Box 2_RGT2020137/RGT2158708, SBS reagents_SBS box 1_RGT2120666/RGT2167122, SBS reagents_SBS box 2_RGT2176218/REA0266475, SBS reagents_TRUSEQ MULTIPLEX_RGT2090581/REA0207987		703279	RNA sequencing result	SDY301_EXP13728_RNA_seq.703279.tsv	SDY301_EXP13728_RNA_seq.tsv
SUB133809	Homo sapiens	Black or African American		Not Hispanic or Latino		Female	Age at enrollment		64	Years	Healthy	ARM2107	AIRFV 2012-13	SDY301	Systems Biology Approach to Analysis of 2012-13 TIV Fluzone Influenza Vaccine Response in Healthy Individuals (see companion studies SDY74, SDY296)	BS720976			Other		0	Days	Time of initial vaccine administration			PV2143	1	EXP13728	ES789737		OTHER	SDY-300_C2_NONE	ESR12499, ESR12500, ESR12501, ESR12502, ESR12503, ESR12504, ESR12505, ESR12506, ESR12507, ESR12508, ESR12509	TRUSEQ RNA SAMPLE PREP KIT V2_Box A, TRUSEQ RNA SAMPLE PREP KIT V2_Box 1, TRUSEQ RNA SAMPLE PREP KIT V2_Box 2_8441530/8527616 combined, TRUSEQ RNA SAMPLE PREP KIT V2_PCR Box, Cluster generation_Reagent_GA2001014-PE3/GA2158702-PE3, Cluster generation_Flow cell_COUMKACXX/D16B4ACXX, Cluster generation_Manifold, TRUSEQ PE CLUSTER KIT V3_Box 2_RGT2020137/RGT2158708, SBS reagents_SBS box 1_RGT2120666/RGT2167122, SBS reagents_SBS box 2_RGT2176218/REA0266475, SBS reagents_TRUSEQ MULTIPLEX_RGT2090581/REA0207987		703279	RNA sequencing result	SDY301_EXP13728_RNA_seq.703279.tsv	SDY301_EXP13728_RNA_seq.tsv
SUB133809	Homo sapiens	Black or African American		Not Hispanic or Latino		Female	Age at enrollment		64	Years	Healthy	ARM2107	AIRFV 2012-13	SDY301	Systems Biology Approach to Analysis of 2012-13 TIV Fluzone Influenza Vaccine Response in Healthy Individuals (see companion studies SDY74, SDY296)	BS720977			Other		0	Days	Time of initial vaccine administration			PV2143	1	EXP13728	ES789738		OTHER	SDY-300_C2_NONE	ESR12499, ESR12500, ESR12501, ESR12502, ESR12503, ESR12504, ESR12505, ESR12506, ESR12507, ESR12508, ESR12509	TRUSEQ RNA SAMPLE PREP KIT V2_Box A, TRUSEQ RNA SAMPLE PREP KIT V2_Box 1, TRUSEQ RNA SAMPLE PREP KIT V2_Box 2_8441530/8527616 combined, TRUSEQ RNA SAMPLE PREP KIT V2_PCR Box, Cluster generation_Reagent_GA2001014-PE3/GA2158702-PE3, Cluster generation_Flow cell_COUMKACXX/D16B4ACXX, Cluster generation_Manifold, TRUSEQ PE CLUSTER KIT V3_Box 2_RGT2020137/RGT2158708, SBS reagents_SBS box 1_RGT2120666/RGT2167122, SBS reagents_SBS box 2_RGT2176218/REA0266475, SBS reagents_TRUSEQ MULTIPLEX_RGT2090581/REA0207987		703279	RNA sequencing result	SDY301_EXP13728_RNA_seq.703279.tsv	SDY301_EXP13728_RNA_seq.tsv
SUB133809	Homo sapiens	Black or African American		Not Hispanic or Latino		Female	Age at enrollment		64	Years	Healthy	ARM2107	AIRFV 2012-13	SDY301	Systems Biology Approach to Analysis of 2012-13 TIV Fluzone Influenza Vaccine Response in Healthy Individuals (see companion studies SDY74, SDY296)	BS721001			Other		0	Days	Time of initial vaccine administration			PV2143	1	EXP13728	ES789762		OTHER	SDY-300_C2_NONE	ESR12499, ESR12500, ESR12501, ESR12502, ESR12503, ESR12504, ESR12505, ESR12506, ESR12507, ESR12508, ESR12509	TRUSEQ RNA SAMPLE PREP KIT V2_Box A, TRUSEQ RNA SAMPLE PREP KIT V2_Box 1, TRUSEQ RNA SAMPLE PREP KIT V2_Box 2_8441530/8527616 combined, TRUSEQ RNA SAMPLE PREP KIT V2_PCR Box, Cluster generation_Reagent_GA2001014-PE3/GA2158702-PE3, Cluster generation_Flow cell_COUMKACXX/D16B4ACXX, Cluster generation_Manifold, TRUSEQ PE CLUSTER KIT V3_Box 2_RGT2020137/RGT2158708, SBS reagents_SBS box 1_RGT2120666/RGT2167122, SBS reagents_SBS box 2_RGT2176218/REA0266475, SBS reagents_TRUSEQ MULTIPLEX_RGT2090581/REA0207987		703279	RNA sequencing result	SDY301_EXP13728_RNA_seq.703279.tsv	SDY301_EXP13728_RNA_seq.tsv
SUB133809	Homo sapiens	Black or African American		Not Hispanic or Latino		Female	Age at enrollment		64	Years	Healthy	ARM2107	AIRFV 2012-13	SDY301	Systems Biology Approach to Analysis of 2012-13 TIV Fluzone Influenza Vaccine Response in Healthy Individuals (see companion studies SDY74, SDY296)	BS721002			Other		0	Days	Time of initial vaccine administration			PV2143	1	EXP13728	ES789763		OTHER	SDY-300_C2_NONE	ESR12499, ESR12500, ESR12501, ESR12502, ESR12503, ESR12504, ESR12505, ESR12506, ESR12507, ESR12508, ESR12509	TRUSEQ RNA SAMPLE PREP KIT V2_Box A, TRUSEQ RNA SAMPLE PREP KIT V2_Box 1, TRUSEQ RNA SAMPLE PREP KIT V2_Box 2_8441530/8527616 combined, TRUSEQ RNA SAMPLE PREP KIT V2_PCR Box, Cluster generation_Reagent_GA2001014-PE3/GA2158702-PE3, Cluster generation_Flow cell_COUMKACXX/D16B4ACXX, Cluster generation_Manifold, TRUSEQ PE CLUSTER KIT V3_Box 2_RGT2020137/RGT2158708, SBS reagents_SBS box 1_RGT2120666/RGT2167122, SBS reagents_SBS box 2_RGT2176218/REA0266475, SBS reagents_TRUSEQ MULTIPLEX_RGT2090581/REA0207987		703279	RNA sequencing result	SDY301_EXP13728_RNA_seq.703279.tsv	SDY301_EXP13728_RNA_seq.tsv
SUB133809	Homo sapiens	Black or African American		Not Hispanic or Latino		Female	Age at enrollment		64	Years	Healthy	ARM2107	AIRFV 2012-13	SDY301	Systems Biology Approach to Analysis of 2012-13 TIV Fluzone Influenza Vaccine Response in Healthy Individuals (see companion studies SDY74, SDY296)	BS721030			Other		0	Days	Time of initial vaccine administration			PV2143	1	EXP13728	ES789791		OTHER	SDY-300_C2_NONE	ESR12499, ESR12500, ESR12501, ESR12502, ESR12503, ESR12504, ESR12505, ESR12506, ESR12507, ESR12508, ESR12509	TRUSEQ RNA SAMPLE PREP KIT V2_Box A, TRUSEQ RNA SAMPLE PREP KIT V2_Box 1, TRUSEQ RNA SAMPLE PREP KIT V2_Box 2_8441530/8527616 combined, TRUSEQ RNA SAMPLE PREP KIT V2_PCR Box, Cluster generation_Reagent_GA2001014-PE3/GA2158702-PE3, Cluster generation_Flow cell_COUMKACXX/D16B4ACXX, Cluster generation_Manifold, TRUSEQ PE CLUSTER KIT V3_Box 2_RGT2020137/RGT2158708, SBS reagents_SBS box 1_RGT2120666/RGT2167122, SBS reagents_SBS box 2_RGT2176218/REA0266475, SBS reagents_TRUSEQ MULTIPLEX_RGT2090581/REA0207987		703279	RNA sequencing result	SDY301_EXP13728_RNA_seq.703279.tsv	SDY301_EXP13728_RNA_seq.tsv
SUB133809	Homo sapiens	Black or African American		Not Hispanic or Latino		Female	Age at enrollment		64	Years	Healthy	ARM2107	AIRFV 2012-13	SDY301	Systems Biology Approach to Analysis of 2012-13 TIV Fluzone Influenza Vaccine Response in Healthy Individuals (see companion studies SDY74, SDY296)	BS721058			Other		0	Days	Time of initial vaccine administration			PV2143	1	EXP13728	ES789819		OTHER	SDY-300_C2_NONE	ESR12499, ESR12500, ESR12501, ESR12502, ESR12503, ESR12504, ESR12505, ESR12506, ESR12507, ESR12508, ESR12509	TRUSEQ RNA SAMPLE PREP KIT V2_Box A, TRUSEQ RNA SAMPLE PREP KIT V2_Box 1, TRUSEQ RNA SAMPLE PREP KIT V2_Box 2_8441530/8527616 combined, TRUSEQ RNA SAMPLE PREP KIT V2_PCR Box, Cluster generation_Reagent_GA2001014-PE3/GA2158702-PE3, Cluster generation_Flow cell_COUMKACXX/D16B4ACXX, Cluster generation_Manifold, TRUSEQ PE CLUSTER KIT V3_Box 2_RGT2020137/RGT2158708, SBS reagents_SBS box 1_RGT2120666/RGT2167122, SBS reagents_SBS box 2_RGT2176218/REA0266475, SBS reagents_TRUSEQ MULTIPLEX_RGT2090581/REA0207987		703279	RNA sequencing result	SDY301_EXP13728_RNA_seq.703279.tsv	SDY301_EXP13728_RNA_seq.tsv
SUB133810	Homo sapiens	Black or African American		Not Hispanic or Latino		Female	Age at enrollment		22	Years	Healthy	ARM2107	AIRFV 2012-13	SDY301	Systems Biology Approach to Analysis of 2012-13 TIV Fluzone Influenza Vaccine Response in Healthy Individuals (see companion studies SDY74, SDY296)	BS720978			Other		0	Days	Time of initial vaccine administration			PV2143	1	EXP13728	ES789739		OTHER	SDY-300_C2_NONE	ESR12499, ESR12500, ESR12501, ESR12502, ESR12503, ESR12504, ESR12505, ESR12506, ESR12507, ESR12508, ESR12509	TRUSEQ RNA SAMPLE PREP KIT V2_Box A, TRUSEQ RNA SAMPLE PREP KIT V2_Box 1, TRUSEQ RNA SAMPLE PREP KIT V2_Box 2_8441530/8527616 combined, TRUSEQ RNA SAMPLE PREP KIT V2_PCR Box, Cluster generation_Reagent_GA2001014-PE3/GA2158702-PE3, Cluster generation_Flow cell_COUMKACXX/D16B4ACXX, Cluster generation_Manifold, TRUSEQ PE CLUSTER KIT V3_Box 2_RGT2020137/RGT2158708, SBS reagents_SBS box 1_RGT2120666/RGT2167122, SBS reagents_SBS box 2_RGT2176218/REA0266475, SBS reagents_TRUSEQ MULTIPLEX_RGT2090581/REA0207987		703279	RNA sequencing result	SDY301_EXP13728_RNA_seq.703279.tsv	SDY301_EXP13728_RNA_seq.tsv
SUB133810	Homo sapiens	Black or African American		Not Hispanic or Latino		Female	Age at enrollment		22	Years	Healthy	ARM2107	AIRFV 2012-13	SDY301	Systems Biology Approach to Analysis of 2012-13 TIV Fluzone Influenza Vaccine Response in Healthy Individuals (see companion studies SDY74, SDY296)	BS721003			Other		0	Days	Time of initial vaccine administration			PV2143	1	EXP13728	ES789764		OTHER	SDY-300_C2_NONE	ESR12499, ESR12500, ESR12501, ESR12502, ESR12503, ESR12504, ESR12505, ESR12506, ESR12507, ESR12508, ESR12509	TRUSEQ RNA SAMPLE PREP KIT V2_Box A, TRUSEQ RNA SAMPLE PREP KIT V2_Box 1, TRUSEQ RNA SAMPLE PREP KIT V2_Box 2_8441530/8527616 combined, TRUSEQ RNA SAMPLE PREP KIT V2_PCR Box, Cluster generation_Reagent_GA2001014-PE3/GA2158702-PE3, Cluster generation_Flow cell_COUMKACXX/D16B4ACXX, Cluster generation_Manifold, TRUSEQ PE CLUSTER KIT V3_Box 2_RGT2020137/RGT2158708, SBS reagents_SBS box 1_RGT2120666/RGT2167122, SBS reagents_SBS box 2_RGT2176218/REA0266475, SBS reagents_TRUSEQ MULTIPLEX_RGT2090581/REA0207987		703279	RNA sequencing result	SDY301_EXP13728_RNA_seq.703279.tsv	SDY301_EXP13728_RNA_seq.tsv
SUB133810	Homo sapiens	Black or African American		Not Hispanic or Latino		Female	Age at enrollment		22	Years	Healthy	ARM2107	AIRFV 2012-13	SDY301	Systems Biology Approach to Analysis of 2012-13 TIV Fluzone Influenza Vaccine Response in Healthy Individuals (see companion studies SDY74, SDY296)	BS721059			Other		0	Days	Time of initial vaccine administration			PV2143	1	EXP13728	ES789820		OTHER	SDY-300_C2_NONE	ESR12499, ESR12500, ESR12501, ESR12502, ESR12503, ESR12504, ESR12505, ESR12506, ESR12507, ESR12508, ESR12509	TRUSEQ RNA SAMPLE PREP KIT V2_Box A, TRUSEQ RNA SAMPLE PREP KIT V2_Box 1, TRUSEQ RNA SAMPLE PREP KIT V2_Box 2_8441530/8527616 combined, TRUSEQ RNA SAMPLE PREP KIT V2_PCR Box, Cluster generation_Reagent_GA2001014-PE3/GA2158702-PE3, Cluster generation_Flow cell_COUMKACXX/D16B4ACXX, Cluster generation_Manifold, TRUSEQ PE CLUSTER KIT V3_Box 2_RGT2020137/RGT2158708, SBS reagents_SBS box 1_RGT2120666/RGT2167122, SBS reagents_SBS box 2_RGT2176218/REA0266475, SBS reagents_TRUSEQ MULTIPLEX_RGT2090581/REA0207987		703279	RNA sequencing result	SDY301_EXP13728_RNA_seq.703279.tsv	SDY301_EXP13728_RNA_seq.tsv
SUB133811	Homo sapiens	Black or African American		Not Hispanic or Latino		Male	Age at enrollment		26	Years	Healthy	ARM2107	AIRFV 2012-13	SDY301	Systems Biology Approach to Analysis of 2012-13 TIV Fluzone Influenza Vaccine Response in Healthy Individuals (see companion studies SDY74, SDY296)	BS720979			Other		0	Days	Time of initial vaccine administration			PV2143	1	EXP13728	ES789740		OTHER	SDY-300_C2_NONE	ESR12499, ESR12500, ESR12501, ESR12502, ESR12503, ESR12504, ESR12505, ESR12506, ESR12507, ESR12508, ESR12509	TRUSEQ RNA SAMPLE PREP KIT V2_Box A, TRUSEQ RNA SAMPLE PREP KIT V2_Box 1, TRUSEQ RNA SAMPLE PREP KIT V2_Box 2_8441530/8527616 combined, TRUSEQ RNA SAMPLE PREP KIT V2_PCR Box, Cluster generation_Reagent_GA2001014-PE3/GA2158702-PE3, Cluster generation_Flow cell_COUMKACXX/D16B4ACXX, Cluster generation_Manifold, TRUSEQ PE CLUSTER KIT V3_Box 2_RGT2020137/RGT2158708, SBS reagents_SBS box 1_RGT2120666/RGT2167122, SBS reagents_SBS box 2_RGT2176218/REA0266475, SBS reagents_TRUSEQ MULTIPLEX_RGT2090581/REA0207987		703279	RNA sequencing result	SDY301_EXP13728_RNA_seq.703279.tsv	SDY301_EXP13728_RNA_seq.tsv
SUB133811	Homo sapiens	Black or African American		Not Hispanic or Latino		Male	Age at enrollment		26	Years	Healthy	ARM2107	AIRFV 2012-13	SDY301	Systems Biology Approach to Analysis of 2012-13 TIV Fluzone Influenza Vaccine Response in Healthy Individuals (see companion studies SDY74, SDY296)	BS721004			Other		0	Days	Time of initial vaccine administration			PV2143	1	EXP13728	ES789765		OTHER	SDY-300_C2_NONE	ESR12499, ESR12500, ESR12501, ESR12502, ESR12503, ESR12504, ESR12505, ESR12506, ESR12507, ESR12508, ESR12509	TRUSEQ RNA SAMPLE PREP KIT V2_Box A, TRUSEQ RNA SAMPLE PREP KIT V2_Box 1, TRUSEQ RNA SAMPLE PREP KIT V2_Box 2_8441530/8527616 combined, TRUSEQ RNA SAMPLE PREP KIT V2_PCR Box, Cluster generation_Reagent_GA2001014-PE3/GA2158702-PE3, Cluster generation_Flow cell_COUMKACXX/D16B4ACXX, Cluster generation_Manifold, TRUSEQ PE CLUSTER KIT V3_Box 2_RGT2020137/RGT2158708, SBS reagents_SBS box 1_RGT2120666/RGT2167122, SBS reagents_SBS box 2_RGT2176218/REA0266475, SBS reagents_TRUSEQ MULTIPLEX_RGT2090581/REA0207987		703279	RNA sequencing result	SDY301_EXP13728_RNA_seq.703279.tsv	SDY301_EXP13728_RNA_seq.tsv
SUB133811	Homo sapiens	Black or African American		Not Hispanic or Latino		Male	Age at enrollment		26	Years	Healthy	ARM2107	AIRFV 2012-13	SDY301	Systems Biology Approach to Analysis of 2012-13 TIV Fluzone Influenza Vaccine Response in Healthy Individuals (see companion studies SDY74, SDY296)	BS721031			Other		0	Days	Time of initial vaccine administration			PV2143	1	EXP13728	ES789792		OTHER	SDY-300_C2_NONE	ESR12499, ESR12500, ESR12501, ESR12502, ESR12503, ESR12504, ESR12505, ESR12506, ESR12507, ESR12508, ESR12509	TRUSEQ RNA SAMPLE PREP KIT V2_Box A, TRUSEQ RNA SAMPLE PREP KIT V2_Box 1, TRUSEQ RNA SAMPLE PREP KIT V2_Box 2_8441530/8527616 combined, TRUSEQ RNA SAMPLE PREP KIT V2_PCR Box, Cluster generation_Reagent_GA2001014-PE3/GA2158702-PE3, Cluster generation_Flow cell_COUMKACXX/D16B4ACXX, Cluster generation_Manifold, TRUSEQ PE CLUSTER KIT V3_Box 2_RGT2020137/RGT2158708, SBS reagents_SBS box 1_RGT2120666/RGT2167122, SBS reagents_SBS box 2_RGT2176218/REA0266475, SBS reagents_TRUSEQ MULTIPLEX_RGT2090581/REA0207987		703279	RNA sequencing result	SDY301_EXP13728_RNA_seq.703279.tsv	SDY301_EXP13728_RNA_seq.tsv
SUB133811	Homo sapiens	Black or African American		Not Hispanic or Latino		Male	Age at enrollment		26	Years	Healthy	ARM2107	AIRFV 2012-13	SDY301	Systems Biology Approach to Analysis of 2012-13 TIV Fluzone Influenza Vaccine Response in Healthy Individuals (see companion studies SDY74, SDY296)	BS721060			Other		0	Days	Time of initial vaccine administration			PV2143	1	EXP13728	ES789821		OTHER	SDY-300_C2_NONE	ESR12499, ESR12500, ESR12501, ESR12502, ESR12503, ESR12504, ESR12505, ESR12506, ESR12507, ESR12508, ESR12509	TRUSEQ RNA SAMPLE PREP KIT V2_Box A, TRUSEQ RNA SAMPLE PREP KIT V2_Box 1, TRUSEQ RNA SAMPLE PREP KIT V2_Box 2_8441530/8527616 combined, TRUSEQ RNA SAMPLE PREP KIT V2_PCR Box, Cluster generation_Reagent_GA2001014-PE3/GA2158702-PE3, Cluster generation_Flow cell_COUMKACXX/D16B4ACXX, Cluster generation_Manifold, TRUSEQ PE CLUSTER KIT V3_Box 2_RGT2020137/RGT2158708, SBS reagents_SBS box 1_RGT2120666/RGT2167122, SBS reagents_SBS box 2_RGT2176218/REA0266475, SBS reagents_TRUSEQ MULTIPLEX_RGT2090581/REA0207987		703279	RNA sequencing result	SDY301_EXP13728_RNA_seq.703279.tsv	SDY301_EXP13728_RNA_seq.tsv
SUB133812	Homo sapiens	Black or African American		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Healthy	ARM2107	AIRFV 2012-13	SDY301	Systems Biology Approach to Analysis of 2012-13 TIV Fluzone Influenza Vaccine Response in Healthy Individuals (see companion studies SDY74, SDY296)	BS720980			Other		0	Days	Time of initial vaccine administration			PV2143	1	EXP13728	ES789741		OTHER	SDY-300_C2_NONE	ESR12499, ESR12500, ESR12501, ESR12502, ESR12503, ESR12504, ESR12505, ESR12506, ESR12507, ESR12508, ESR12509	TRUSEQ RNA SAMPLE PREP KIT V2_Box A, TRUSEQ RNA SAMPLE PREP KIT V2_Box 1, TRUSEQ RNA SAMPLE PREP KIT V2_Box 2_8441530/8527616 combined, TRUSEQ RNA SAMPLE PREP KIT V2_PCR Box, Cluster generation_Reagent_GA2001014-PE3/GA2158702-PE3, Cluster generation_Flow cell_COUMKACXX/D16B4ACXX, Cluster generation_Manifold, TRUSEQ PE CLUSTER KIT V3_Box 2_RGT2020137/RGT2158708, SBS reagents_SBS box 1_RGT2120666/RGT2167122, SBS reagents_SBS box 2_RGT2176218/REA0266475, SBS reagents_TRUSEQ MULTIPLEX_RGT2090581/REA0207987		703279	RNA sequencing result	SDY301_EXP13728_RNA_seq.703279.tsv	SDY301_EXP13728_RNA_seq.tsv
SUB133812	Homo sapiens	Black or African American		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Healthy	ARM2107	AIRFV 2012-13	SDY301	Systems Biology Approach to Analysis of 2012-13 TIV Fluzone Influenza Vaccine Response in Healthy Individuals (see companion studies SDY74, SDY296)	BS721032			Other		0	Days	Time of initial vaccine administration			PV2143	1	EXP13728	ES789793		OTHER	SDY-300_C2_NONE	ESR12499, ESR12500, ESR12501, ESR12502, ESR12503, ESR12504, ESR12505, ESR12506, ESR12507, ESR12508, ESR12509	TRUSEQ RNA SAMPLE PREP KIT V2_Box A, TRUSEQ RNA SAMPLE PREP KIT V2_Box 1, TRUSEQ RNA SAMPLE PREP KIT V2_Box 2_8441530/8527616 combined, TRUSEQ RNA SAMPLE PREP KIT V2_PCR Box, Cluster generation_Reagent_GA2001014-PE3/GA2158702-PE3, Cluster generation_Flow cell_COUMKACXX/D16B4ACXX, Cluster generation_Manifold, TRUSEQ PE CLUSTER KIT V3_Box 2_RGT2020137/RGT2158708, SBS reagents_SBS box 1_RGT2120666/RGT2167122, SBS reagents_SBS box 2_RGT2176218/REA0266475, SBS reagents_TRUSEQ MULTIPLEX_RGT2090581/REA0207987		703279	RNA sequencing result	SDY301_EXP13728_RNA_seq.703279.tsv	SDY301_EXP13728_RNA_seq.tsv
SUB133812	Homo sapiens	Black or African American		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Healthy	ARM2107	AIRFV 2012-13	SDY301	Systems Biology Approach to Analysis of 2012-13 TIV Fluzone Influenza Vaccine Response in Healthy Individuals (see companion studies SDY74, SDY296)	BS721061			Other		0	Days	Time of initial vaccine administration			PV2143	1	EXP13728	ES789822		OTHER	SDY-300_C2_NONE	ESR12499, ESR12500, ESR12501, ESR12502, ESR12503, ESR12504, ESR12505, ESR12506, ESR12507, ESR12508, ESR12509	TRUSEQ RNA SAMPLE PREP KIT V2_Box A, TRUSEQ RNA SAMPLE PREP KIT V2_Box 1, TRUSEQ RNA SAMPLE PREP KIT V2_Box 2_8441530/8527616 combined, TRUSEQ RNA SAMPLE PREP KIT V2_PCR Box, Cluster generation_Reagent_GA2001014-PE3/GA2158702-PE3, Cluster generation_Flow cell_COUMKACXX/D16B4ACXX, Cluster generation_Manifold, TRUSEQ PE CLUSTER KIT V3_Box 2_RGT2020137/RGT2158708, SBS reagents_SBS box 1_RGT2120666/RGT2167122, SBS reagents_SBS box 2_RGT2176218/REA0266475, SBS reagents_TRUSEQ MULTIPLEX_RGT2090581/REA0207987		703279	RNA sequencing result	SDY301_EXP13728_RNA_seq.703279.tsv	SDY301_EXP13728_RNA_seq.tsv
SUB133813	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		47	Years	Healthy	ARM2107	AIRFV 2012-13	SDY301	Systems Biology Approach to Analysis of 2012-13 TIV Fluzone Influenza Vaccine Response in Healthy Individuals (see companion studies SDY74, SDY296)	BS720981			Other		0	Days	Time of initial vaccine administration			PV2143	1	EXP13728	ES789742		OTHER	SDY-300_C2_NONE	ESR12499, ESR12500, ESR12501, ESR12502, ESR12503, ESR12504, ESR12505, ESR12506, ESR12507, ESR12508, ESR12509	TRUSEQ RNA SAMPLE PREP KIT V2_Box A, TRUSEQ RNA SAMPLE PREP KIT V2_Box 1, TRUSEQ RNA SAMPLE PREP KIT V2_Box 2_8441530/8527616 combined, TRUSEQ RNA SAMPLE PREP KIT V2_PCR Box, Cluster generation_Reagent_GA2001014-PE3/GA2158702-PE3, Cluster generation_Flow cell_COUMKACXX/D16B4ACXX, Cluster generation_Manifold, TRUSEQ PE CLUSTER KIT V3_Box 2_RGT2020137/RGT2158708, SBS reagents_SBS box 1_RGT2120666/RGT2167122, SBS reagents_SBS box 2_RGT2176218/REA0266475, SBS reagents_TRUSEQ MULTIPLEX_RGT2090581/REA0207987		703279	RNA sequencing result	SDY301_EXP13728_RNA_seq.703279.tsv	SDY301_EXP13728_RNA_seq.tsv
SUB133813	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		47	Years	Healthy	ARM2107	AIRFV 2012-13	SDY301	Systems Biology Approach to Analysis of 2012-13 TIV Fluzone Influenza Vaccine Response in Healthy Individuals (see companion studies SDY74, SDY296)	BS721005			Other		0	Days	Time of initial vaccine administration			PV2143	1	EXP13728	ES789766		OTHER	SDY-300_C2_NONE	ESR12499, ESR12500, ESR12501, ESR12502, ESR12503, ESR12504, ESR12505, ESR12506, ESR12507, ESR12508, ESR12509	TRUSEQ RNA SAMPLE PREP KIT V2_Box A, TRUSEQ RNA SAMPLE PREP KIT V2_Box 1, TRUSEQ RNA SAMPLE PREP KIT V2_Box 2_8441530/8527616 combined, TRUSEQ RNA SAMPLE PREP KIT V2_PCR Box, Cluster generation_Reagent_GA2001014-PE3/GA2158702-PE3, Cluster generation_Flow cell_COUMKACXX/D16B4ACXX, Cluster generation_Manifold, TRUSEQ PE CLUSTER KIT V3_Box 2_RGT2020137/RGT2158708, SBS reagents_SBS box 1_RGT2120666/RGT2167122, SBS reagents_SBS box 2_RGT2176218/REA0266475, SBS reagents_TRUSEQ MULTIPLEX_RGT2090581/REA0207987		703279	RNA sequencing result	SDY301_EXP13728_RNA_seq.703279.tsv	SDY301_EXP13728_RNA_seq.tsv
SUB133813	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		47	Years	Healthy	ARM2107	AIRFV 2012-13	SDY301	Systems Biology Approach to Analysis of 2012-13 TIV Fluzone Influenza Vaccine Response in Healthy Individuals (see companion studies SDY74, SDY296)	BS721033			Other		0	Days	Time of initial vaccine administration			PV2143	1	EXP13728	ES789794		OTHER	SDY-300_C2_NONE	ESR12499, ESR12500, ESR12501, ESR12502, ESR12503, ESR12504, ESR12505, ESR12506, ESR12507, ESR12508, ESR12509	TRUSEQ RNA SAMPLE PREP KIT V2_Box A, TRUSEQ RNA SAMPLE PREP KIT V2_Box 1, TRUSEQ RNA SAMPLE PREP KIT V2_Box 2_8441530/8527616 combined, TRUSEQ RNA SAMPLE PREP KIT V2_PCR Box, Cluster generation_Reagent_GA2001014-PE3/GA2158702-PE3, Cluster generation_Flow cell_COUMKACXX/D16B4ACXX, Cluster generation_Manifold, TRUSEQ PE CLUSTER KIT V3_Box 2_RGT2020137/RGT2158708, SBS reagents_SBS box 1_RGT2120666/RGT2167122, SBS reagents_SBS box 2_RGT2176218/REA0266475, SBS reagents_TRUSEQ MULTIPLEX_RGT2090581/REA0207987		703279	RNA sequencing result	SDY301_EXP13728_RNA_seq.703279.tsv	SDY301_EXP13728_RNA_seq.tsv
SUB133813	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		47	Years	Healthy	ARM2107	AIRFV 2012-13	SDY301	Systems Biology Approach to Analysis of 2012-13 TIV Fluzone Influenza Vaccine Response in Healthy Individuals (see companion studies SDY74, SDY296)	BS721062			Other		0	Days	Time of initial vaccine administration			PV2143	1	EXP13728	ES789823		OTHER	SDY-300_C2_NONE	ESR12499, ESR12500, ESR12501, ESR12502, ESR12503, ESR12504, ESR12505, ESR12506, ESR12507, ESR12508, ESR12509	TRUSEQ RNA SAMPLE PREP KIT V2_Box A, TRUSEQ RNA SAMPLE PREP KIT V2_Box 1, TRUSEQ RNA SAMPLE PREP KIT V2_Box 2_8441530/8527616 combined, TRUSEQ RNA SAMPLE PREP KIT V2_PCR Box, Cluster generation_Reagent_GA2001014-PE3/GA2158702-PE3, Cluster generation_Flow cell_COUMKACXX/D16B4ACXX, Cluster generation_Manifold, TRUSEQ PE CLUSTER KIT V3_Box 2_RGT2020137/RGT2158708, SBS reagents_SBS box 1_RGT2120666/RGT2167122, SBS reagents_SBS box 2_RGT2176218/REA0266475, SBS reagents_TRUSEQ MULTIPLEX_RGT2090581/REA0207987		703279	RNA sequencing result	SDY301_EXP13728_RNA_seq.703279.tsv	SDY301_EXP13728_RNA_seq.tsv
SUB133814	Homo sapiens	White		Hispanic or Latino		Female	Age at enrollment		50	Years	Healthy	ARM2107	AIRFV 2012-13	SDY301	Systems Biology Approach to Analysis of 2012-13 TIV Fluzone Influenza Vaccine Response in Healthy Individuals (see companion studies SDY74, SDY296)	BS720967			Other		0	Days	Time of initial vaccine administration			PV2143	1	EXP13728	ES789728		OTHER	SDY-300_C2_NONE	ESR12499, ESR12500, ESR12501, ESR12502, ESR12503, ESR12504, ESR12505, ESR12506, ESR12507, ESR12508, ESR12509	TRUSEQ RNA SAMPLE PREP KIT V2_Box A, TRUSEQ RNA SAMPLE PREP KIT V2_Box 1, TRUSEQ RNA SAMPLE PREP KIT V2_Box 2_8441530/8527616 combined, TRUSEQ RNA SAMPLE PREP KIT V2_PCR Box, Cluster generation_Reagent_GA2001014-PE3/GA2158702-PE3, Cluster generation_Flow cell_COUMKACXX/D16B4ACXX, Cluster generation_Manifold, TRUSEQ PE CLUSTER KIT V3_Box 2_RGT2020137/RGT2158708, SBS reagents_SBS box 1_RGT2120666/RGT2167122, SBS reagents_SBS box 2_RGT2176218/REA0266475, SBS reagents_TRUSEQ MULTIPLEX_RGT2090581/REA0207987		703279	RNA sequencing result	SDY301_EXP13728_RNA_seq.703279.tsv	SDY301_EXP13728_RNA_seq.tsv
SUB133814	Homo sapiens	White		Hispanic or Latino		Female	Age at enrollment		50	Years	Healthy	ARM2107	AIRFV 2012-13	SDY301	Systems Biology Approach to Analysis of 2012-13 TIV Fluzone Influenza Vaccine Response in Healthy Individuals (see companion studies SDY74, SDY296)	BS720982			Other		0	Days	Time of initial vaccine administration			PV2143	1	EXP13728	ES789743		OTHER	SDY-300_C2_NONE	ESR12499, ESR12500, ESR12501, ESR12502, ESR12503, ESR12504, ESR12505, ESR12506, ESR12507, ESR12508, ESR12509	TRUSEQ RNA SAMPLE PREP KIT V2_Box A, TRUSEQ RNA SAMPLE PREP KIT V2_Box 1, TRUSEQ RNA SAMPLE PREP KIT V2_Box 2_8441530/8527616 combined, TRUSEQ RNA SAMPLE PREP KIT V2_PCR Box, Cluster generation_Reagent_GA2001014-PE3/GA2158702-PE3, Cluster generation_Flow cell_COUMKACXX/D16B4ACXX, Cluster generation_Manifold, TRUSEQ PE CLUSTER KIT V3_Box 2_RGT2020137/RGT2158708, SBS reagents_SBS box 1_RGT2120666/RGT2167122, SBS reagents_SBS box 2_RGT2176218/REA0266475, SBS reagents_TRUSEQ MULTIPLEX_RGT2090581/REA0207987		703279	RNA sequencing result	SDY301_EXP13728_RNA_seq.703279.tsv	SDY301_EXP13728_RNA_seq.tsv
SUB133814	Homo sapiens	White		Hispanic or Latino		Female	Age at enrollment		50	Years	Healthy	ARM2107	AIRFV 2012-13	SDY301	Systems Biology Approach to Analysis of 2012-13 TIV Fluzone Influenza Vaccine Response in Healthy Individuals (see companion studies SDY74, SDY296)	BS720992			Other		0	Days	Time of initial vaccine administration			PV2143	1	EXP13728	ES789753		OTHER	SDY-300_C2_NONE	ESR12499, ESR12500, ESR12501, ESR12502, ESR12503, ESR12504, ESR12505, ESR12506, ESR12507, ESR12508, ESR12509	TRUSEQ RNA SAMPLE PREP KIT V2_Box A, TRUSEQ RNA SAMPLE PREP KIT V2_Box 1, TRUSEQ RNA SAMPLE PREP KIT V2_Box 2_8441530/8527616 combined, TRUSEQ RNA SAMPLE PREP KIT V2_PCR Box, Cluster generation_Reagent_GA2001014-PE3/GA2158702-PE3, Cluster generation_Flow cell_COUMKACXX/D16B4ACXX, Cluster generation_Manifold, TRUSEQ PE CLUSTER KIT V3_Box 2_RGT2020137/RGT2158708, SBS reagents_SBS box 1_RGT2120666/RGT2167122, SBS reagents_SBS box 2_RGT2176218/REA0266475, SBS reagents_TRUSEQ MULTIPLEX_RGT2090581/REA0207987		703279	RNA sequencing result	SDY301_EXP13728_RNA_seq.703279.tsv	SDY301_EXP13728_RNA_seq.tsv
SUB133814	Homo sapiens	White		Hispanic or Latino		Female	Age at enrollment		50	Years	Healthy	ARM2107	AIRFV 2012-13	SDY301	Systems Biology Approach to Analysis of 2012-13 TIV Fluzone Influenza Vaccine Response in Healthy Individuals (see companion studies SDY74, SDY296)	BS721006			Other		0	Days	Time of initial vaccine administration			PV2143	1	EXP13728	ES789767		OTHER	SDY-300_C2_NONE	ESR12499, ESR12500, ESR12501, ESR12502, ESR12503, ESR12504, ESR12505, ESR12506, ESR12507, ESR12508, ESR12509	TRUSEQ RNA SAMPLE PREP KIT V2_Box A, TRUSEQ RNA SAMPLE PREP KIT V2_Box 1, TRUSEQ RNA SAMPLE PREP KIT V2_Box 2_8441530/8527616 combined, TRUSEQ RNA SAMPLE PREP KIT V2_PCR Box, Cluster generation_Reagent_GA2001014-PE3/GA2158702-PE3, Cluster generation_Flow cell_COUMKACXX/D16B4ACXX, Cluster generation_Manifold, TRUSEQ PE CLUSTER KIT V3_Box 2_RGT2020137/RGT2158708, SBS reagents_SBS box 1_RGT2120666/RGT2167122, SBS reagents_SBS box 2_RGT2176218/REA0266475, SBS reagents_TRUSEQ MULTIPLEX_RGT2090581/REA0207987		703279	RNA sequencing result	SDY301_EXP13728_RNA_seq.703279.tsv	SDY301_EXP13728_RNA_seq.tsv
SUB133814	Homo sapiens	White		Hispanic or Latino		Female	Age at enrollment		50	Years	Healthy	ARM2107	AIRFV 2012-13	SDY301	Systems Biology Approach to Analysis of 2012-13 TIV Fluzone Influenza Vaccine Response in Healthy Individuals (see companion studies SDY74, SDY296)	BS721021			Other		0	Days	Time of initial vaccine administration			PV2143	1	EXP13728	ES789782		OTHER	SDY-300_C2_NONE	ESR12499, ESR12500, ESR12501, ESR12502, ESR12503, ESR12504, ESR12505, ESR12506, ESR12507, ESR12508, ESR12509	TRUSEQ RNA SAMPLE PREP KIT V2_Box A, TRUSEQ RNA SAMPLE PREP KIT V2_Box 1, TRUSEQ RNA SAMPLE PREP KIT V2_Box 2_8441530/8527616 combined, TRUSEQ RNA SAMPLE PREP KIT V2_PCR Box, Cluster generation_Reagent_GA2001014-PE3/GA2158702-PE3, Cluster generation_Flow cell_COUMKACXX/D16B4ACXX, Cluster generation_Manifold, TRUSEQ PE CLUSTER KIT V3_Box 2_RGT2020137/RGT2158708, SBS reagents_SBS box 1_RGT2120666/RGT2167122, SBS reagents_SBS box 2_RGT2176218/REA0266475, SBS reagents_TRUSEQ MULTIPLEX_RGT2090581/REA0207987		703279	RNA sequencing result	SDY301_EXP13728_RNA_seq.703279.tsv	SDY301_EXP13728_RNA_seq.tsv
SUB133814	Homo sapiens	White		Hispanic or Latino		Female	Age at enrollment		50	Years	Healthy	ARM2107	AIRFV 2012-13	SDY301	Systems Biology Approach to Analysis of 2012-13 TIV Fluzone Influenza Vaccine Response in Healthy Individuals (see companion studies SDY74, SDY296)	BS721034			Other		0	Days	Time of initial vaccine administration			PV2143	1	EXP13728	ES789795		OTHER	SDY-300_C2_NONE	ESR12499, ESR12500, ESR12501, ESR12502, ESR12503, ESR12504, ESR12505, ESR12506, ESR12507, ESR12508, ESR12509	TRUSEQ RNA SAMPLE PREP KIT V2_Box A, TRUSEQ RNA SAMPLE PREP KIT V2_Box 1, TRUSEQ RNA SAMPLE PREP KIT V2_Box 2_8441530/8527616 combined, TRUSEQ RNA SAMPLE PREP KIT V2_PCR Box, Cluster generation_Reagent_GA2001014-PE3/GA2158702-PE3, Cluster generation_Flow cell_COUMKACXX/D16B4ACXX, Cluster generation_Manifold, TRUSEQ PE CLUSTER KIT V3_Box 2_RGT2020137/RGT2158708, SBS reagents_SBS box 1_RGT2120666/RGT2167122, SBS reagents_SBS box 2_RGT2176218/REA0266475, SBS reagents_TRUSEQ MULTIPLEX_RGT2090581/REA0207987		703279	RNA sequencing result	SDY301_EXP13728_RNA_seq.703279.tsv	SDY301_EXP13728_RNA_seq.tsv
SUB133814	Homo sapiens	White		Hispanic or Latino		Female	Age at enrollment		50	Years	Healthy	ARM2107	AIRFV 2012-13	SDY301	Systems Biology Approach to Analysis of 2012-13 TIV Fluzone Influenza Vaccine Response in Healthy Individuals (see companion studies SDY74, SDY296)	BS721049			Other		0	Days	Time of initial vaccine administration			PV2143	1	EXP13728	ES789810		OTHER	SDY-300_C2_NONE	ESR12499, ESR12500, ESR12501, ESR12502, ESR12503, ESR12504, ESR12505, ESR12506, ESR12507, ESR12508, ESR12509	TRUSEQ RNA SAMPLE PREP KIT V2_Box A, TRUSEQ RNA SAMPLE PREP KIT V2_Box 1, TRUSEQ RNA SAMPLE PREP KIT V2_Box 2_8441530/8527616 combined, TRUSEQ RNA SAMPLE PREP KIT V2_PCR Box, Cluster generation_Reagent_GA2001014-PE3/GA2158702-PE3, Cluster generation_Flow cell_COUMKACXX/D16B4ACXX, Cluster generation_Manifold, TRUSEQ PE CLUSTER KIT V3_Box 2_RGT2020137/RGT2158708, SBS reagents_SBS box 1_RGT2120666/RGT2167122, SBS reagents_SBS box 2_RGT2176218/REA0266475, SBS reagents_TRUSEQ MULTIPLEX_RGT2090581/REA0207987		703279	RNA sequencing result	SDY301_EXP13728_RNA_seq.703279.tsv	SDY301_EXP13728_RNA_seq.tsv
SUB133814	Homo sapiens	White		Hispanic or Latino		Female	Age at enrollment		50	Years	Healthy	ARM2107	AIRFV 2012-13	SDY301	Systems Biology Approach to Analysis of 2012-13 TIV Fluzone Influenza Vaccine Response in Healthy Individuals (see companion studies SDY74, SDY296)	BS721063			Other		0	Days	Time of initial vaccine administration			PV2143	1	EXP13728	ES789824		OTHER	SDY-300_C2_NONE	ESR12499, ESR12500, ESR12501, ESR12502, ESR12503, ESR12504, ESR12505, ESR12506, ESR12507, ESR12508, ESR12509	TRUSEQ RNA SAMPLE PREP KIT V2_Box A, TRUSEQ RNA SAMPLE PREP KIT V2_Box 1, TRUSEQ RNA SAMPLE PREP KIT V2_Box 2_8441530/8527616 combined, TRUSEQ RNA SAMPLE PREP KIT V2_PCR Box, Cluster generation_Reagent_GA2001014-PE3/GA2158702-PE3, Cluster generation_Flow cell_COUMKACXX/D16B4ACXX, Cluster generation_Manifold, TRUSEQ PE CLUSTER KIT V3_Box 2_RGT2020137/RGT2158708, SBS reagents_SBS box 1_RGT2120666/RGT2167122, SBS reagents_SBS box 2_RGT2176218/REA0266475, SBS reagents_TRUSEQ MULTIPLEX_RGT2090581/REA0207987		703279	RNA sequencing result	SDY301_EXP13728_RNA_seq.703279.tsv	SDY301_EXP13728_RNA_seq.tsv
